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ABSTRACT 
CHARACTERIZATION OF A PUTATIVE TONB DEFICIENT PORPHYROMONAS 
GINGIVALIS MUTANT 
By: Soheil Rostami, B.S. 
A thesis submitted in partial fulfillment of the requirements for the degree of Masters of 
Science at Virginia Commonwealth University 
Virginia Commonwealth University, 2014 
Major Director: Janina P. Lewis, Ph.D., Philips Institute of Oral Health Research 
 Porphorymonas gingivalis is one of the major bacterial pathogens responsible for 
the initiation and progression of periodontal disease. The bacterium requires hemin 
uptake for its growth and has developed sophisticated mechanisms to extract hemin 
from hemin containing proteins in the oral cavity. Hemin first binds to receptors on the 
surface of P. gingivalis and is then taken up in an energy dependent manner. TonB is 
an inner membrane bound protein that spans the periplasm and is believed to be 
involved in the passage of hemin through the double membrane of P. gingivalis. 
However, the TonB protein in P. gingivalis is yet to be identified. We identified PG0785 
as a possible P. gingivalis TonB based on its bioinformatics data showing similarity to 
other known TonB proteins. We generated a P. gingivalis mutant lacking a functional 
PG0785 and then characterized the mutant to determine the role of PG0785. We 
performed metal content and protease assays, virulence studies and transcriptional and 
translational analysis of our mutant and wild type P. gingivalis strains. 
 Phenotypic studies showed that the mutant cannot accumulate hemin on its 
surface. The mutant has significantly lower levels of iron compared to wild type based 
  
 
on metal content assays. The mutant also has significantly lower protease activity 
compared to the wild type. Virulence studies showed that the mutant interacted and 
invaded eukaryotic cells at much lower levels than the wild type. These results allowed 
us to speculate that PG0785 is very important in binding of hemin to surface of P. 
gingivalis. PG0785 also plays an important role in iron uptake, protease activity and 
virulence of P. gingivalis. Transcriptional and translational analyses have shown that 
numerous TonB related genes, metal uptake genes, hemin uptake genes and genes 
related to virulence have been differentially regulated in the mutant lacking a functional 
PG0785 gene compared to the wild type strain. In conclusion we believe that based on 
our results PG0785 is a putative P. gingivalis TonB protein that plays a significant role in 
the biology of P. gingivalis.  
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CHAPTER 1: BACKGROUND AND SIGNIFICANCE 
1.1 Introduction 
 Porphyromonas gingivalis is a Gram-negative, rod-shaped, anaerobic bacteria 
that belongs to the phylum Bacteriodetes. Biological studies have shown that P. 
gingivalis is one of the main etiological agents involved in initiation and progression of 
periodontal disease. Periodontal disease is one of the most common inflammatory 
diseases worldwide and is believed to affect as much as 35% of the US population. P. 
gingivalis contains many virulence factors that allow it to escape the host immune 
response and colonize the sub-gingival area and periodontal pockets. These virulence 
factors are also associated with the release of many pro-inflammatory cytokines which 
lead to the extensive inflammatory response seen during periodontal disease.  
 P. gingivalis requires iron for its growth and it mainly acquires iron in the form of 
hemin derived from hemoproteins present in the oral cavity. P. gingivalis contains 
proteases that degrade hemin containing proteins such as hemoglobin which leads to 
release of hemin. Hemin then binds to the surface of P. gingivalis and is then taken up 
in an energy dependent manner. The TonB/ExbB/ExbD complex is believed to play a 
major role in the passage of hemin through the double-membrane of P. gingivalis. The 
inner membrane of the bacterium generates a proton motive force (pmf) that is 
transferred via ExbB/ExbD to TonB. TonB spans the periplasm and interacts with outer-
membrane receptors that have bound hemin. This interaction leads to the plug domain 
of these receptors to be removed from inside of the receptors which then allows for 
hemin to be taken up through the receptor. 
 2 
 
1.2 Periodontal Disease  
Periodontal disease is a chronic inflammatory disease that is characterized by an 
increased inflammatory response affecting the periodontium. The increased levels of 
cytokines and polymorphonuclear leukocyte (PMN) in gingival tissue lead to alveolar 
bone loss and destruction of connective tissue and periodontal ligament. Periodontal 
disease develops from pre-existing gingivitis, although not all gingivitis progresses to 
periodontal disease (Brown et al., 1989). Recently it’s been estimated that as many as 
75% of Americans are affected by gingivitis and 35% have some form of periodontal 
disease (Amar et al., 2003; Albandar et al., 1999). Clinically a periodontal pocket of 4 
mm or more is associated with periodontal disease and a pocket of 6 mm or more is 
associated with advanced or severe form of the disease (Elter et al., 2004; Hujoel et al., 
2000) 
The trigger for the initiation of disease is the accumulation of microorganisms in a 
biofilm known as plaque (Smalley et al., 2002). Initially it was believed that only gram-
negative microorganisms contribute to periodontal disease. However, recent reports 
have show that gram-positive bacteria can also be cultured from diseased sites 
suggesting that both gram-negative and gram-positive bacteria contribute to the disease 
(Kumar et al., 2005). Over 700 bacterial species are present in the periodontal pockets 
but only around 10-20 bacterial species play a major role in pathogenesis of periodontal 
disease (Amar et al., 2003; Socransky and Haffajee, 1994). Some of these bacterial 
species include Porphyromonas gingivalis, Tannerella forsythia, Aggregatibacter 
actinomycetemcomitans, Prevotella intermedia, Prevotella melaninogenica and 
Fusobacterium nucleatum (Teles et al., 2013). The ‘red complex’ consists of 
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Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia which are 
thought to be three major periodontal pathogens (Holt et al., 2005). P. gingivalis has 
been detected in as much as 85% of disease sites and is frequently associated with 
severe periodontal disease (Yang et al., 2004). The major pathogenic bacteria 
associated with the disease have developed mechanisms to evade the host immune 
response which allows them to colonize and invade the gingival epithelial cells. They 
also contain mediators that lead to induction of an inflammatory response which can 
lead to connective tissue damage and alveolar bone loss (Mahanonda et al., 1991; 
Darveau et al., 1997).  
Periodontal disease is associated with multiple risk factors that are thought to 
increase the probability of the disease. Some of these risk factors include the microbial 
plaque found in the periodontal pocket, increased age, smoking and systemic diseases 
such as diabetes mellitus (Horning et al., 1992; Stoltenberg et al., 1993, Oliver and 
Tervonen, 1993). It is also believed that conditions that affect the antibacterial defense 
mechanisms such as human immunodeficiency virus (HIV) and neutrophil disorders can 
also increase the risk of periodontal disease (Loesche et al., 2001). Periodontal disease 
has also been implicated as a risk factor for several systemic diseases. The increased 
inflammatory responses due to increased inflammatory cytokines and C-reactive 
species can increase the risk for coronary heart disease, preterm low birth weight, 
stroke and artheroclerosis (Bahekar et al., 2007; Lopez et al., 2002; Pussinen et al., 
2004) 
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1.3 Porphyromonas gingivalis 
Porphryomonas gingivalis is a Gram-negative, rod-shaped, anaerobic bacteria 
that belongs to the phylum Bacteriodetes (Shah and Collins, 1988). When grown on 
blood plates, the bacterial colonies initially display a white color, however, eventually the 
colonies become dark pigmented due to the accumulation of heme on their surface 
(Smalley et al. 1998). P. gingivalis is asaccharolytic due to its inability to break down 
sugars and carbohydrates. As a result the bacterium utilizes energy produced from 
proteolytic breakdown of various proteins. P. gingivalis is believed to be one of the main 
causative pathogens in initiation and progression of periodontal disease (Socransky and 
Haffajee, 1994). It belongs to a group of three species known as the “red complex”. This 
complex includes Porphyromonas gingivalis, Treponema denticola and Tannerella 
forsythia, all of which have been strongly associated with diseased sites during 
periodontal disease (Holt et al., 2005). These three pathogenic species can cause a 
change in the microbiota of the oral cavity and induce an inflammatory response that 
can lead to periodontal disease. As a result, P. gingivalis is believed to be a “keystone 
pathogen”. A “keystone pathogen” is pathogen that can remodel a normal microbiota 
into a disease-provoking microbiota which can lead to initiation of inflammatory 
diseases (Hajishengallis et al., 2012).  
P. gingivalis is mainly found in the oral cavity where it can colonize the 
periodontal pocket and invade the gingival epithelial cells (Sandros et al., 1995; Matto et 
al., 1998). It has also been cultured from other body parts such as the umbilical cord, 
coronary artery endothelial cells, lung abscesses and atherosclerotic plaques (Beck et 
al., 1998; Dorn et al., 2001; Okuda et al., 2005; Kozarov et al., 2005). It is a late 
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colonizer in the oral cavity and requires other established organisms to create the 
necessary environmental conditions for it to be able to proliferate. These conditions 
include providing attachment sites, growth substrates and reduction of oxygen to low 
enough levels that would allow for survival of anaerobic bacteria (Nonaka et al., 2001; 
Kamaguchi et al., 2003).  
During colonization and invasion of the oral tissue, reactive oxidative species 
such as O2·
−, HO·, and H2O2 are found in the oral environment (Imlay, 2002; Park et al., 
1992). Exposure of P. gingivalis to this oxidative stress condition poses a challenge to 
the survival and proliferation of the bacteria. However, the bacterium has established 
effective protective mechanisms against this oxidative stress. P. gingivalis contains 
superoxide dismutase which provides protection against atmospheric oxygen (Lynch & 
Kuramitsu, 1998). It also contains OxyR, a redox-sensitive protein, and rubrerythrin 
which provide resistance to H2O2 exposure and aerotolerance (Harley et al., 1981; 
Sztukowska et al., 2002). The bacteria can also withstand nitrosative stress conditions 
by expressing HcpR, a regulator of the hybrid cluster protein (Hcp). The hydroxylamine 
produced from nitrite or nitric oxide is reduced into water and ammonia by Hcp (Wolfe et 
al., 2002). The HcpR of P. gingivalis can bind to the hcp promoter causing elevated 
levels of Hcp which protects the bacteria against nitrosative stress (Lewis et al., 2012).  
Evasion of the host immune response is necessary for the survival of P. 
gingivalis during colonization and invasion. Interleukin-8 (IL-8) is essential for local 
defense against organisms by recruiting neutrophils to the site of infection (Baggiolini et 
al., 1992). P. gingivalis can inhibit gingival epithelial cells from producing IL-8 which 
prevents recruitment of neutrophils to the target site (Darveau et al., 1998). It’s been 
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reported that the capsule of P. gingivalis can also prevent activation of the complement 
pathway (Brunner et al., 2010). Gingipain-dependent degradation of C3 also allows the 
bacteria to suppress complement activation (Popadiak et al., 2007). After evading the 
immune response and establishing colonization, the bacterial mediators will cause an 
increase in production of inflammatory cytokines such as IL-1β, tumor necrosis factor- α  
(TNF-α), IL-6, and IL-8 (Darveau, 2010; Baker et al., 1999). This leads to stimulation of 
an inflammatory response which stimulates bone and tissue destruction in the 
periodontal area (Lindemann et al., 1988). 
Iron is an essential component for the growth of nearly all organisms. P. 
gingivalis obtains iron in the form of hemin (iron and protoporphyrin IX) which becomes 
available after proteolytical break down of hemin containing proteins such as 
hemoglobin (Schifferle et al., 1996; Shizukuishi et al., 1995). Accumulation of hemin on 
the cell surface of P. gingivalis gives it its black pigmentation and protects the bacteria 
from oxidative stress (Smalley et al., 1998). 
1.4 Virulence Factors of P. gingivalis 
1.4.1. Capsule 
The capsule is an extracellular, hydrophilic polysaccharide coating the surface of 
the bacteria (Bayer and Bayer, 1994). It has been implicated in evasion of the immune 
response by down-regulating phagocytosis, opsonization and the complement system 
(Domenico et al., 1994; Noel et al., 1992). Studies have shown that P. gingivalis strains 
that express capsule have an increase in resistance to phagocytosis compared to non-
encapsulated strains (Sundqvist et al., 1991; Van Winkelhoff et al. 1993). This increase 
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in resistance could be due to both increased hydrophilicity of the different strains and a 
decrease in activation of the complement pathway (Schifferle et al., 1993).  
Encapsulated P. gingivalis strains have also been demonstrated to reduce 
production of cytokines such as IL-1, IL-6 and IL-8 which further supports the role of 
capsule in evasion of the immune response (Brunner et al., 2010). The adaptive 
response has also been shown to be down-regulated and less effective in response to 
P. gingivalis strains containing a capsule (Wilensky, 2009). In a recent study by Lewis et 
al., mice that were infected with a non-encapsulated mutant of P. gingivalis W50 had a 
much higher survival rate than those treated with an encapsulated P. gingivalis W50 
(Singh et al., 2011). This result demonstrates that encapsulated strains of P. gingivalis 
indeed have an increase in virulence compared to non-encapsulated strains. 
1.4.2. Lipopolysaccharide 
Lipopolysaccharides (LPS) are found on the outer membrane of gram-negative 
bacteria such as P. gingivalis. LPS plays a crucial role in mediating inflammation and 
stimulation of pro-inflammatory cytokines which produce an inflammatory response that 
leads to bone resorption. The Lipid-A moiety of LPS is believed to mediate binding of 
LPS to host receptors and its composition is dependent of varying hemin concentrations 
(Cutler et al., 1996). The tetra-acylated form of the Lipid-A moiety is a Toll-Like 
Receptor 4 (TLR4) antagonist and the penta-acylated form is a TLR4 agonists (Nemoto 
et al., 2006; Darveau et al., 2004). When hemin concentration is low, the penta-acylated 
form is abundant which allows LPS to bind and activate TLR4 (Al-Qutub et al., 2006).  
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Activation of TLR4 triggers activation of many inflammatory signaling pathways 
including nuclear factor- kB (NF-kB), c-Jun N-terminal kinase (JNK) and p38 mitogen-
activated protein kinase (p38MAPK) (Wang et al., 2002; Ip and Davis, 1998; Lu et al., 
2001). Activation of these pathways lead to stimulation of many inflammatory cytokines 
such as interleukin-1β (IL-1β), tumor necrosis factor-α (TNF- α) and IL-6 which lead to 
initiation of an inflammatory response (Chiang et al., 1999; Nishida et al., 2001). 
1.4.3. Fimbriae 
P. gingivalis expresses two distinct fimbriae on its cell surface. Type I or major 
fimbriae are long, filamentous components on the cell surface and are encoded by the 
fimA gene and range from 41 to 49 kDa in size depending on the strain (Lee et al., 
1991). They have many roles including cell adhesion and invasion, mediating 
inflammatory response, biofilm formation and immune evasion. Recent studies have 
shown that P. gingivalis mutants deficient in FimA had both reduced adhesion and a 
significant reduction in invasion of human oral epithelial cells (Njoroge et al., 1997; 
Weinberg et al., 1997). Type I fimbria play a role in bone resorption by stimulating 
release of pro-inflammatory cytokines. These fimbriae can stimulate TLR2 and CD14 
which promotes release of pro-inflammatory cytokines such as TNF-a, IL-1B, IL-8 and 
IL-6 from epithelial and endothelial cells (Asai et al., 2001; Davey et al., 2008; Ogawa et 
al., 2002). A previous study demonstrated that rats infected with a fimA deficient P. 
gingivalis mutant showed reduced bone loss compared to mice infected with the 
wildtype strain further supporting the role of fimbriae in bone degradation during 
periodontal disease (Malek et al., 1994).  
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Type I fimbriae have also been shown to play a role in evasion of cell-mediated 
immunity. It’s been demonstrated that these fimbria can interact with complement 
receptor 3 (CR3) causing inhibition of IL-12. This leads to reduction in levels of 
interferon-γ (IFN- γ), an activator of cell-mediated immunity, thus promoting the survival 
of P. gingivalis (Hajishengallis et al., 2007; Hajishengallis, 2011).Type I fimbriae 
mediate co-adhesion of P. gingivalis with many other bacteria such as Treponema 
denticola and Streptococcus oralis and promote biofilm formation (Hashimoto et al., 
2003; Maeda et al., 2004; Kuboniwa et al., 2009). 
Type II or minor fimbriae are short, secondary structures that are encoded by the 
mfa1 gene and have a molecular mass of 67 kDa (Hamada et al., 1996). Their role is 
less known then type I fimbriae but they have been shown to play a role in cell adhesion 
and invasion, biofilm formation and inflammatory response. Certain strains of P. 
gingivalis such as W50 and W83 do not posses type I fimbriae and are only covered 
with type II fimbriae. These strains are still invasive indicating that type II fimbriae play a 
role in invasion of epithelial cells. A recent study demonstrated that an mfa1-deficient P. 
gingivalis mutant had reduced invasion of epithelial cells which supports the role of type 
II fimbriae in adhesion and invasion (Umemoto and Hamada, 2003). Type II fimbriae 
have also been shown to be necessary for interaction of P. gingivalis with 
Streptococcus gordonii during biofilm formation (Park et al., 2005). This indicates that 
both type I and type II fimbriae play a role in biofilm formation. Type II fimbriae can 
mediate bone resorption by inducing an inflammatory response via release of cytokines 
such as IL-1α, IL-1β, IL-6 and TNF-α (Hamada et al., 2002).  
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1.4.4. Gingipains 
P. gingivalis proteases are referred to as gingipains. Gingipains can be found as 
soluble, extracellular entities but they are mostly located on the outer membrane of the 
bacteria. They are a group of trypsin-like cysteine proteinases that are believed to be 
responsible for at least 85% percent of the proteolytic activity of P. gingivalis (Potempa 
et al. 2003). There are at least three genes that encode these cysteine proteinases. 
These include rgpA which encodes arginine-specific gingipain A (RgpA), rgpB which 
codes for arginine-specific gingipain B (RgpB) and the kgp gene which codes for a 
lysine-specific gingipain (Kgp) (Lewis et al., 1998, Potempa et al. 1995). 
 The RgpA contains a signal sequence, an arginine-specific catalytic domain and 
a C-terminal hemagglutinin/adhesion domain (Pavloff et al., 1995). The rgpB domain 
however, only codes for a signal sequence and a catalytic domain (Mikolajczyk-
Pawlinska et al., 1998). Just like RgpA, Kgp contains a polyprotein which consists of a 
profragment containing a signal sequence, a lysine-specific catalytic domain and a C-
terminal hemagglutinin/adhesion domain (Pavloff et al., 1997). The C-terminal adhesion 
domain of the gingipains is responsible for binding of the bacteria to a variety of 
substrates such as hemoglobin, fibrinogen, fibronectin, transferrin and red blood cells 
(Pike et al., 1996; Nakayama et al., 1998; Brochu et al., 2001). The adhesion domain 
has also been demonstrated to play a role in co-colonization of P. gingivalis with other 
bacteria in the periodontal pockets during plaque formation (Kamaguchi et al., 2003). 
The catalytic domain of the gingipains is responsible for degradation of many host 
proteins such as plasma proteins, extracellular matrix proteins, cytokines and host cell 
surface proteins (Sroka et al., 2001; Potempa et al., 2003).  
 11 
 
 Gingipains have many different biological roles and contribute greatly to the 
virulence of P. gingivalis. They can play a role in establishment of chronic inflammation 
by stimulating expression of receptors in neutrophils, epithelial cells and fibroblasts 
which lead to induction of pro-inflammatory cytokine response (Lourbakos et al., 1997; 
Lourbakos et al., 2001; Belibasakis et al., 2010). Gingipains can deteriorate the cell-
mediated immune response by cleaving multiple T-cell receptors, such as CD2, CD4 
and CD8 (Kitamura et al., 2002). Arginine-gingipains also have a significant role in 
allowing the bacteria to evade the complement system by cleaving the C5 and C3 
molecules. Cleaving the C5 molecule prevents recruitment of PMNs and degradation of 
the C3 molecule leads to a decrease in bacterial opsonization (Wingrove et al., 1992; 
Imamura et al., 2001; Sroka et al., 2001).  
One of the major roles of gingipains is their ability to degrade heme containing 
proteins which are essential for P. gingivalis growth. Recent studies have demonstrated 
that lysine-gingipains play a major role in binding and degrading hemoglobin and other 
heme containing proteins (Lewis et al., 1999). It has also been shown that arginine-
gingipains play a major role in degrading hemoglobin (Fujimura et al., 1998).     
1.4.5. Hemagglutinin 
 P. gingivalis contains five hemagglutinin proteins encoded by hagA, hagB, hagC, 
hagD and hagE genes. Mutations in the hagA, hagB and hagC genes caused a 
reduction in the hemagglutinating activity of the bacteria which suggests that these 
genes are important in hemagglutination of the P. gingivalis (Lepine et al., 1996).  
Hemagglutitins are thought to promote colonization of P. gingivalis by allowing for 
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adhering of the bacteria with the host epithelial cells (Duncan et al., 1996). These 
proteins also play a role in hemin uptake by P. gingivalis by mediating the binding of the 
bacteria to erythrocytes in the periodontal pocket (Lepine and Progulske-Fox, 1996).  
1.5 Iron  
1.5.1. Iron Uptake 
 Iron is an essential nutrient for the growth of almost all organisms. Biologically, 
iron participates in many processes such as photosynthesis, methanogenesis, H2 
production and consumption, respiration, tricholoracetic acid cycle, oxygen transport 
and DNA biosynthesis. Iron exits in two forms: the reduced form as a ferrous iron (Fe2+) 
or the oxidized form as ferric iron (Fe3+). Ferrous iron is much more soluble in water and 
it is highly reactive (Boukhalfa & Crumbliss, 2002). Because of its ability to be reduced 
or oxidized, iron is an essential component of life. However, free iron is also capable of 
catalyzing the conversion of hydrogen peroxides into free radicals which can lead to 
high toxicity. Due to their high reactivity, these radicals can react with nucleic acids, 
proteins and lipids and produce significant damage that could kill the cells. As a result 
the free iron is sequestered into protein-bound forms to prevent the increase in free 
radicals and toxicity. Many high affinity binding proteins such as transferrin, lactoferrin 
and ferritin bind free iron (Otto et al., 1992). However, majority of iron is often found as 
heme in proteins that are associated with transporting oxygen such as hemoglobin or 
myoglobin. It is believed that as much as 95% of heme is bound to proteins (Bridges & 
Seligman, 1995). This leads to low free iron concentrations inside the host which does 
not support bacterial life. As a result organisms have developed specific mechanisms to 
extract iron from proteins in order to successfully survive. Some of these pathogens 
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contain small iron-chelating molecules called siderophores (Cornelissen & Sparling, 
1994). These are high-affinity Fe3+ scavengers which can outcompete the host’s 
scavenging ability and sequester iron from iron-containing proteins. Other bacteria such 
as P. gingivalis do not contain siderophores and rely on the proteolytic degradation of 
hemin-binding proteins and/or expression of binding receptors that are capable of 
wrestling the iron from proteins. Lysis of erythrocytes releases hemoglobin which is then 
rapidly bound to haptoglobin, hemopexin and albumin (Hwang & Greer 1980; Hrkal et 
al., 1974; Beaven et al., 1974).  
1.5.2. P. gingivalis and Iron  
 Iron plays a crucial role in the growth and virulence of P. gingivalis. Reduction of 
fumarate to succinate by fumarate reductase is a crucial pathway in production of 
energy in P. gingivalis. Hemin is essential for the synthesis of cytochrome b subunit of 
the fumarate reductase in P. gingivalis (Macy et al., 1975). The bacterium does not 
have the ability to produce protoporphyrin IX, a component of hemin, and thus relies on 
exogenous uptake of hemin for growth (Shah et al., 1979). Hemin also has the ability to 
bind to surface of P. gingivalis which protects the bacteria against oxidative stress 
(Smalley et al., 1998). Hemin also plays a role in protection of P. gingivalis against 
nitrosative conditions. Hemin is required for the binding of HcpR to the hcp promoter 
leading to elevated levels of Hcp which protects the bacteria from nitrosative stress 
(Lewis et al., 2012). Recent studies have demonstrated that this bacteria uses hemin 
from hemoglobin more effectively than other iron binding proteins, although transferrin 
and lactoferrin have both been shown to support the growth of the organism 
(Shizukuishi et al., 1995; Lamont & Jenkinson, 1998). P. gingivalis has developed 
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mechanisms for both lysing of red blood cells which releases hemoglobin and lysing of 
hemoglobin which releases hemin. As discussed earlier, this organism encodes a family 
of proteases termed gingipains. These gingipains contain an N-terminal proteolytic 
domain and a C-terminal adhesion domain which has the ability to bind substrates such 
as red blood cells (Curtis et al., 2001; Imamura, 2003). P. gingivalis also contains 
hemagglutinins such as HagB and HagC which are also capable of binding erythrocytes 
(Progulske-Fox et al. 1995). After binding the erythrocytes, the various hemolysins of P. 
gingivalis cause lysing of the erythrocytes which leads to the release of hemoglobin 
(Chu et al., 1991; Nelson et al., 2003). The Kgp and Rgp gingipains of the bacterium will 
then bind hemoglobin and then degrade the hemoglobin which leads to the release of 
hemin (Lewis et al., 1999; Sroka et al., 2001). Once hemin is released from hemoglobin, 
P. gingivalis must bind it via receptors on its surface and transport it across its double 
membrane. Recently it’s been demonstrated that three multigenic clusters exist in the 
bacteria that are believed to encode proteins involved in hemin uptake pathways 
(Nelson et al., 2003). The first locus, ihtABCDE, is composed of five open reading 
fames (ORFs). The ORFs encode for a TonB-dependent outer-membrane receptor 
(ihtA), lipoprotein (ihtB), periplasmic binding protein (ihtC), permease (ihtD) and 
cytoplasmic ATP-binding protein (ihtE) (Dashper et al., 2000). The second locus is 
composed of a TonB-dependent receptor (Tla) followed by an ATP-binding cassette 
hemin-transport system known as htrABCD (Aduse-Opoku et al., 1997; Slakeski et al., 
2000). The third locus, hmu, also has a role in hemin uptake (Lewis et al., 2001). The 
locus cosists of hmuY and hmuR which are co-transcribed and repressed in presence of 
iron (Simpson et al., 2000). Recent studies have demonstrated that the HmuY protein is 
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capable of binding hemin and HmuR protein can bind both hemin and hemoglobin (Liu 
et al., 2006; Olcazak et al., 2006). The hmu locus also consists of the hmuSTUV locus 
which could be involved in encoding proteins that process and transport the hemin 
molecule from periplasmic space through the inner membrane.  
1.5.3. TonB 
Transport of heme across the double-membrane of P. gingivalis is a critical step 
in the growth of the bacteria. Due to its large size, heme cannot diffuse across the 
membrane and relies on an energy dependent active transport. The active transport of 
this molecule involves an outer membrane receptor, a periplasmic binding protein and 
an inner membrane ATP-binding cassette transporter (Nikaido, 2003). The inner- 
membrane generates a proton motor force (pmf) that promotes active transport through 
the outer-membrane (Bradbeer, 1993). The periplasm space is estimated to span a 
distance anywhere from 15-71 nm (DePamphlis and Adler, 1971). As a result, a 
mechanism is required to transport the pmf of the inner-membrane to the outer-
membrane. 
The TonB, ExbB, and ExbD complex have been proposed to provide the linkage 
between the inner-membrane and the outer-membrane. ExbB is a 26 kDa cytoplasmic 
membrane protein consisting of three transmembrane domains and a cytoplasmic 
domain (Kampfenkel and Braun, 1993). ExbD is a 17 kDa cytoplasmic membrane 
protein which consists of an N-terminal transmembrane domain and C-terminal domain 
found in the periplasm (Kampfenkel and Braun, 1992). These two proteins are believed 
to be involved in the coupling of TonB to the pmf generated by the inner-membrane 
(Larsen et al., 1999). Previous studies have shown that mutations in the ExbB and 
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ExbD genes in E.coli caused a 90% decrease in the activity of TonB, suggesting that 
the ExbB/ExbD complex is required for TonB activity (Ahmer et al., 1995). TonB is 
believed to be constantly reenergized by the pmf due to its conversion from its high-
affinity outer membrane associated state to its high-affinity cytoplasmic membrane 
associated state by the ExbB/ExbD complex (Letain and Postle, 1997). TonB is a 26 
kDa protein that has a single helical N-terminal transmembrane domain, a proline-rich 
domain and a C-terminal domain located in the periplasm. The hydrophobic sequence 
of the N-terminal domain promotes translocation of TonB into the cytoplasmic 
membrane. The proline-rich spacer spans the periplasm and confers flexibility to TonB 
(Kohler et al, 2010). The C-terminal domain allows for interaction of TonB with the outer 
membrane transporters. Recent studies suggest that TonB forms homodimers which is 
in contrast to previous studies that suggested TonB exists as a monomer (Sauter et al., 
2003; Moeck et al., 2001). The structure of TonB allows for linkage of the inner and 
outer-membrane of bacteria which promotes transduction of the pmf. Outer-membrane 
receptors are composed of a 22 strand Beta-barrel structure with an N-terminal plug 
located inside the beta-barrel. The N-terminal plug contains a seven amino acid 
sequence called the TonB-box which allows for interaction with the C-terminal domain 
of TonB (Larsen et al., 1997). During their interaction, TonB box adopts a beta-strand 
conformation that allows for pairing with the three-stranded beta-sheet of TonB 
(Pawelek et al., 2006; Shultis et al., 2006). Rotation of the TonB in the periplasm causes 
removal of the plug domain from inside of the receptor. This rotation is energized by the 
electrochemical gradient that is produced from the pmf which is physically connected to 
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the TonB by the ExbB/ExbD complex (Jordan et al., 2013). Interaction of TonB with the 
outer-membrane TonB dependent receptors can be seen in Figure 1.  
Recently four models have been proposed for the mechanism of TonB action. 
The first model proposed, the propeller model, suggests that TonB exists as a dimer 
(Cascales et al., 2001). In this model TonB interacts with the TonB-box and the 
ExbB/ExbD complex use the pmf gradient of the cytoplasmic membrane to generate a 
rotary motion of TonB. This causes a conformational change or release of the plug from 
the beta-barrel structure which then allows for transport across the membrane receptor.   
The second model, the shuttle model, suggests that TonB is associated with both 
the outer membrane and the cytoplasmic membrane (Letain and Postle, 1997). In this 
model, the pmf of the cytoplasmic membrane is used by the ExbB/ExbD complex to 
convert TonB from an unenergized state to an energized state. The TonB then detaches 
from the cytoplasmic membrane and spans the periplasm to interact with the TonB-box. 
The energy released from TonB causes a conformational change in the plug domain 
which then allows for transport across the receptor.  
The pulling model suggests that both the plug domain and the TonB-TonB-box 
complex are 4-stranded beta-sheets (Brockwell et al., 2003; Gumbart et al., 2007). In 
this model, the TonB spans across the periplasm, interacts with the TonB-box and 
applies a force on the plug domain. The force applied on the plug domain causes 
unfolding of the 4-stranded Beta-sheets which allows for transport of substrates across 
the membrane.  
Finally, the PBP-assisted model is based on the interaction of TonB with FhuD 
which is the periplasmic siderophore binding protein (Carter et al., 2006). In this model, 
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TonB first presents FhuD to FhuA which is an outer membrane transporter. TonB then 
interacts with the TonB-box which leads to a conformational change in the plug domain 
that leads to transport of the siderophore. Finally TonB moves FhuD to FhuBC, the 
inner membrane transporter, which allows movement of the siderophore into the 
cytoplasm. The PBP-assisted model is not associated with the uptake of heme in P. 
gingivalis as this bacteria does not use siderophores. 
Currently no P. gingivalis TonB-coding genes have been identified and thus 
nothing is known about the exact role, mechanism or structure of P. gingivalis TonB. 
Since TonB has been proposed to play a role in hemin uptake and P. gingivalis requires 
hemin for growth, then further investigation of a possible P. gingivalis TonB protein 
could provide useful information about the exact mechanism of hemin uptake in P. 
gingivalis. To further investigate the role of P. gingivalis TonB, we wanted to generate a 
P. gingivalis mutant that was deficient in a putative TonB and characterize the mutant to 
see the roles that this putatitve TonB plays in the biology of P. gingivalis 
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Figure 1: Cartoon representation of the TonB/ExbD/ExbB complex. The proton 
motive force generated in the inner membrane is transferred via ExbD/ExbB to TonB. 
TonB spans the peripasm and interacts via its C-terminal domain with the TonB box of 
the plug domain of TonB dependent receptors. This allows for removal of the plug 
domain from inside of the receptor which allows for hemin to pass through.  
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CHAPTER 2: HYPOTHESIS AND AIMS 
2.1 Hypothesis 
We hypothesize that P. gingivalis candidate protein PG0785 could be a possible 
TonB protein.  
2.2 Research Objective and Aims 
 The main objective of this research is to investigate the role of candidate protein 
PG0785 in P. gingivalis. The objective and aims of the project are depicted in Figure 2.  
Aim 1: Generate a P. gingivalis mutant with a non-functional PG0785 gene using: 
 I. Electroporation to transform the disrupted PG0785 construct into P. 
gingivalis W83 genome. This allows for incorporation of a non-functional PG0785 into 
the genome of W83.   
Aim 2: Determine metal content of V3128 and W83 P. gingivalis strains using: 
 I. ICP-MS metal content analysis which ionizes the samples with inductively 
coupled plasma and then separates and quantifies the ions by a mass spectrometer. 
This allows for quantification of the metal levels in all our samples.   
 II. Colorimetric Ferrozine Assay which allows for quantitation of iron in our 
cultured samples. Both ferric and ferrous iron levels can be quantified using this 
method.  
Aim 3: Determine arginine-specific and lysine-specific cysteine protease activity of 
mutant and wild type P. gingivalis using:  
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 I. Protease assays which is a colorimetric assay that allows for 
measurement of protease activity. Interaction of arginine-specific proteases with BAPNA 
and interaction of lysine-specific proteases with Z-Lys-pNA causes the pNA portion to 
be cleaved off resulting in a yellow color in our samples. More intense colors correlate 
to higher protease activity.  
Aim 4: Determine virulence ability of V3182 and W83 P. gingivalis using: 
 I. Total interaction and invasion assays of V3128 and W83 with HUVEC 
cells. Both V3128 and W83 will be allowed to interact with HUVEC cells and the cultures 
are then plated on blood plates. Colonies are counted to determine how V3128 and 
W83 interact and invade eukaryotic cells.  
 II. Flow Cytometry is an alternative method that allows for measurement of 
interaction and invasion of V3128 and W83 with eukaryotic cells.  
Aim 5: Transcriptional and translational analysis of V3128 and W83 P. gingivalis using: 
 I. Proteomics which allows us to identify proteins that have been differentially 
regulated in V3128 compared to W83.  
 II.RNA isolation and library generation which allows us to identify genes that 
have been differentially regulated in V3128 compared to W83.  
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 Figure 2: Flowchart of the project aims and methods. Project hypothesis and aims 
are listed in the above figure.  
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CHAPTER 3: MATERIALS AND METHODS 
3.1 Mutant Generation 
3.1.2. Growth Media Conditions 
 Porphyromonas gingivalis strain W83 was grown anaerobically at an atmosphere 
of 10% H2, 10% CO2 and 80% N2 at 37
o C. Bacteria liquid cultures were prepared in 
Brain-Heart infusion broth (BHI; Difco Laboratories, Detroit, MI) with Hemin (5 µg/ml; 
Sigma, St. Louis, MO), yeast extract (5 mg/ml), cysteine ( 1mg/ml; Sigma, St. Louis, 
MO) and Vitamin K1 or K2 ( 1 µg/mL; Sigma, St. Louis, MO).     
 
3.1.3. P. gingivalis Cell Preparation 
 Both P. gingivalis V2802 and V2984 W83 strains were grown anaerobically on 
blood agar plates (TSA II, 5% sheep blood; BBL, Cockeysville, MD). From blood plates, 
strains were then grown in 3 ml BHI broth overnight and then again in 1:10 BHI broth 
dilutions overnight. Bacteria from the 1:10 dilutions were then grown in 150 mL BHI 
broth overnight. Cultures were grown until at least an optical density (OD) of 0.300 was 
attained. Cultures were then washed twice with electroporation butter (10% Glycerol; 
Fisher BioReagants) and stored in at -80o C 
.  
3.1.4. Transformation 
 Transformation was done with both W83 strains. PG0785, PG1912 and PG1913 
were cloned into the pCR 2.1 vector using NruI/SmaI, BsmBI/SmaI and NruI/ClaI 
restriction sites respectively. pCR2.1PG0785, pCR2.1PG1912 and pCR2.1PG1913 
plasmids were transformed into P. gingivalis W83 electrocompetent cells using the 
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electroporation method. 10 µL of each plasmid was mixed with 100µL of electroporation 
cells in Electroporation Cuvettes (BIO-RAD, Hercules, CA) and electroporated at 2,500 
mV using a Gene-Pulser (BIO-RAD, Hercules, CA). 500 µL BHI was added to each 
cuvette and cells were grown overnight. From cuvettes containing the 500 µL culture, 
300 µL was then spread on blood agar plates containing 20 µL Clindamycin (0.5 
mg/ml). The plates were then incubated anaerobically for 7 days at 37o C for colonies to 
appear. 
 The plates were inspected for the presence of bacterial colonies. PCR was done 
on selected colonies using the GoTaq® Long PCR Master Mix (Promega). This was 
done to screen for transformation of constructs into the P. gingivalis genome. The PCR 
consisted of 35 cycles consisting of denaturing at 94o C for 30 seconds, annealing at 
52o C for 30 seconds and extension at 65o for 5 minutes. Gel electrophoresis was used 
to confirm the size of the fragment. The electroporation mechanism is shown in Figure 
4.  
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Figure 3: Electroporation method. Plasmids and P. gingivalis W83 cells are mixed 
together in electroporation cuvettes and electroporated at 2500 mV. Bacterial cells are 
then grown in 500 µL of BHI overnight at 37o C. 300 µL of the overnight culture is spread 
on blood plates containing 20 µL of clindamycin. The plates are incubated anaerobically 
for 7 days at 37o C. Colonies are selected from blood plates and screed by PCR. 
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3.2 Identification of a putative TonB gene 
 Bioinformatics was done for PG0785. The protein and nucleotide sequence of 
PG0785 are indicated in Table 1. The Basic Local Alignment Search Tool (BLAST®) 
was used to search the nucleotide and protein sequence of the gene against P. 
gingivalis W83 database. This was used to look at how identical the PG0785 gene is 
compared to genes found in other species. The C-terminal sequence of PG0785 was 
used to attain the structure of C-terminal region of PG0785 using one to one threading 
by Phyre (Kelley and Sternberg, 2009). Chimera was used to generate an overlay of the 
structure of P. gingivalis PG0785 and the structure of the C-terminal TonB protein of E. 
coli.    
Table 1: Nucleotide and protein sequence of PG0785 
Type of Sequence Sequence of PG0785 
Nucleotide  ATGGAAATCAAGAAATCGCCTAAGGCCGACTTGGAGAAGGGAAAAGGTTT 
GAACTTCCTTTTGGGGCTTGTCGTAGCTCTCGCGATCGTGTATGTAGCTT 
TGGAATATCGTACTTACGATAAGATAGAGGCCTATACACGCGATAAAGTG 
GATATTGCCGACATGGAGGAAACTGTCCTGCTCGAAGAAAACGAGCCGGA 
GCCGGAGCAGCCCGAGCCGGAGCAACCCCAGCAACAGGAGGTACAGCTGC 
CGGAAGAATTTAAGGTGGTAGATAACACCCAGAAAGTGGAGAAAATCGCT 
TTGGTCTCTGTCGATGAGAGCAAACCGTTGCCCCCGCCTGCGCCCGTTGC 
CCCCGTTAAAGTTGAGGAAGAAGAGGACAAAATCCACGAAGTGGTAGAAA 
GTCCGGCAGAGTTCCCGGGTGGTTATACTGCTCTCTCTAAATGGCTTAGT 
AAAAATTTGGTCTATCCCGAGCAGGCTGCCGAAATGGGCATCCAAGGTAA 
GGTAATCGTTCGTTTCGTGGTCGAAAAAGATGGTTCTGTGACACAAGCAA 
CTGTTGTTAAGGGTATTGACCCTGCACTTGACAAGGAAGCCCTCCGCGTG 
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ATACAGACTATGCCCAAATGGAAGCCCGGTATGCAGCAGGGAAGAGCTGT 
GCGTGTACGCTGTACCCAGCCCGTCCAGTTCAAGCTGCAA 
Protein Sequence MEIKKSPKADLEKGKGLNFLLGLVVALAIVYVALEYRTYDKIEAYTRDKV 
DIADMEETVLLEENEPEPEQPEPEQPQQQEVQLPEEFKVVDNTQKVEKIA 
LVSVDESKPLPPPAPVAPVKVEEEEDKIHEVVESPAEFPGGYTALSKWLS 
KNLVYPEQAAEMGIQGKVIVRFVVEKDGSVTQATVVKGIDPALDKEALRV 
IQTMPKWKPGMQQGRAVRVRCTQPVQFKLQ 
  
3.3 Eukaryotic Cell Invasion and Total Interaction 
3.3.1. Bacterial Cell Preparation 
Wild type P. gingivalis (W83) and mutant P. gingivalis (V3128) from blood plates 
were inoculated in 4 mls of BHI broth to an OD of 0.5 at 660 nm. Bacteria were 
centrifuged at 7500 rpm for 10 minutes to obtain pellets. Pellets were then washed twice 
with 2 mls Phosphate Buffered Saline (PBS, 0.137 M NaCl, 0.0027 M KCl, 0.010 M 
Na2HPO4, 0.0018 M KH2PO4) and suspended in 2 mls of HUVEC media (Lifeline Cell 
Technology, Table 2).   
3.3.2. Total Interaction Assay 
Human umbilical vein endothelial cells (HUVEC) were grown in 6-well plates until 
at least 80% confluence. Cells in each well were then washed 3 times with PBS and 
suspended in 2 mls of HUVEC media (Table 2). Bacteria were then added to each well 
with a multiplicity of infection (MOI) of 100.  W83 were added to 3 wells and V3128 were 
added to the remaining 3 wells. Bacteria and HUVEC cells were incubated for 30 
minutes before each well was washed twice with PBS. Immediately 2 mls of BHI broth 
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with 1% saponin (Riedel-de Haen, Germany) was added to each well for 15 minutes to 
determine the number of adhered and internalized bacteria. Liquid from each well was 
then collected and serially diluted (1:10 and 1:100). 200 µL from the original tube and 
dilutions were spread on blood plates and incubated anaerobically for 7 days at 37oC 
until colonies appeared.  
3.3.3. Invasion Assay 
HUVEC cells were grown in 6-well plates until at least 80% confluence. Cells in 
each well were then washed 3X with 2 mls of PBS and suspended in 2 mls of HUVEC 
media. Bacteria were then added to each well with an MOI of 100. W83 was added to 3 
wells and V3128 were added to the remaining 3 wells. Bacteria and cells were 
incubated for 30 minutes and then 160 µL of Metronidazole (50 mg/ml; SIGMA®) and 6 
µL of Gentamycin (50 mg/ml; SIGMA®) were added to each well for 1 hour to kill 
externally adhered bacteria. 2 mls of BHI broth with 1 % saponin was added to each 
well for 15 minutes to determine the number of adhered and internalized bacteria. Liquid 
from each well was collected and serially diluted (1:10 and 10:100). 200 µL from the 
undiluted tube and dilutions were spread on blood plates and incubated anaerobically at 
37oC until colonies appeared (Typically around 7-10 days).  
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Table 2: HUVEC Media 
Product Part 
Number 
Volume to 
add 
Final Concentrations in 
Supplemented Medium 
VascuLife Basal Medium LM-0002 475 mL  
VascuLife VEGF LifeFactors 
Kit 
LM-1020  
rh FGF basic LifeFactor  LS-1002 0.5 mL 5 ng/mL 
Ascorbic Acid LifeFactor LS-1005 0.5 mL  50 µg/mL 
Hydrocortisone Sulfate 
LifeFactor 
LS-1007 0.5 mL 1.0 µg/mL 
FBS LifeFactor LS-1012 10 mL 2% 
L-Glutamine LifeFactor LS-1013 25 mL 10 mM 
rh IGF-1 LifeFactor  LS-1014  0.5 mL 15 ng/mL 
rh EGF LifeFactor LS-1015 0.5 mL 5 ng/mL 
rh VEGF LifeFactor LS-1016 0.5 mL 5 ng/mL 
Heparin Sulfate LifeFactor LS-1017 0.5 mL 0.75 units/mL 
Optional Supplements Part 
Number 
Volume to 
add 
Concentrations of 
Supplement 
Phenol Red Supplement LS-1009 1.0 mL 33 mM 
Antimicrobial Supplement: 
Penicillin, Streptomycin and 
Amphotericin B 
LS-1011 1.0 mL Penicillin 10,000 Units/mL 
Streptomycin 10,000 µg/mL 
Amphotericin B 25 µg/mL 
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3.3.4. Flow Cytometry 
 Total interaction and invasion assays were also done using flow cytometry. On 
the day of the reading, W83 and V3128 from blood plates were inoculated in 3 mls of 
BHI media to obtain an OD between 0.5 and 0.7 at 660 nm. Cultures were then 
centrifuged at 7000 rpm for 5 minutes. Pellets were then washed twice with PBS and re-
suspended in 1 ml of PBS. 1 µL of fluorescein-5-EX, succinimidyl ester (FITC) (Life 
Technologies™) was added to each sample and incubated for 1 hour at 4oC. Samples 
were then washed again with PBS and re-suspended in HUVEC media. For total 
interaction, bacterial cells were added to HUVEC cells at an MOI of 100 and incubated 
for 30 minutes. For invasion, bacteria were added to HUVEC cells and the mixture was 
diluted with 0.4% Trypan Blue which quenches extracellular fluorescence and thus only 
allows for counting of bacteria that have invaded cells.  Samples were then taken to the 
Flow Core Facility at VCU (4th floor, MMRB) for fluorescence measurement using the 
BD FACS Canto II flow cytometer.  
3.4 Proteomics 
W83 and V3128 from blood plates were inoculated in 4 mls of BHI broth to an 
OD between 1 - 1.4 at 660 nm. Cultures were then centrifuged at 7500 rpm for 10 
minutes to obtain pellets. Pellets were washed twice with sterile distilled water and re-
suspended in 3 mls of 100 mM Tris-HCL. Cells were then lysed using the sonication 
method and 1 µL of Benzonase (Sigma) was added to each sample for 30 minutes to 
degrade DNA and RNA. 600 µL of 10% Sodium Dodecyl Sulfate (SDS) Solution 
(Invitrogen) was then added to each sample for 30 minutes to unfold the proteins. 
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Samples were then centrifuged at 7500 rpm for 10 minutes and supernatant was 
collected. Both W83 and V3128 proteomic samples were then ran on NuPage 10% Bis-
Tris Gel (Life Technologies™) and lanes of interested were excised from the gel. Both 
proteomic solutions and gel bands were submitted for mass spectrometry analysis to 
the VCU Chemical and Proteomic Mass Spectrometry Core Facility.  
3.5 RNA Library generation 
3.5.1. RNA Isolation 
RNA was isolated from W83 and V3128 using the Qiagen RNeasy® kit. The 
isolated RNA samples were then treated with the DNA-free™ DNase Treatment and 
Removal Reagents kit (Life Technologies™) to remove all DNA. The DNAse treated 
RNA samples were then treated with the Epicentre Ribo-Zero™ Magnetic Kit (Gram-
Negative Bacteria) to deplete rRNA. The rRNA depleted RNA samples were then ready 
for sequencing. 
3.5.2. RNA Library Generation 
 The rRNA depleted RNA samples were treated with the SMARTer® Stranded 
RNA-Seq Kit (Clontech® Laboratories). This kit was used to synthesize cDNA, purify 
cDNA, amplify RNA-sequence library using PCR and purify the RNA-sequence library 
(Figure 4). The generated library was then sent to the VCU Nucleic Acid Research 
Facilities to be validated and sequenced.  
 32 
 
 
Figure 4: Schematic representation of SMARTer® Stranded RNA-Seq Library 
generation adapted from Clontech Laboratories protocol. The Ovation® Complete 
Prokaryotic RNA-Seq DR Multiplex Systems 1-8 and 9-16 (NuGEN) kit was also used to 
generated RNA library. This kit did not require a separate rRNA removal treatment 
because it allowed for non-rRNA library generation by selective priming during first and 
second strand cDNA synthesis. This kit allowed for synthesis of double stranded cDNA, 
fragmentation and purification of cDNA, end repair to generate blunt ends, adaptor 
ligation, strand selection to leave only one cDNA strand and PCR amplification to 
produce the library. The generated library was then sent to the VCU Nucleic Acid 
Research Facilities to be validated and sequenced.  
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3.6  Metal Content Assay 
3.6.1. ICP-MS  
 W83 and V3128 from blood and BHI plates were inoculated in 4 mls of BHI to 
obtain an OD between 1 and 1.4 at 660 nm. Cultures were centrifuged at 7500 rpm for 
10 minutes to harvest bacterial cells. Bacterial pellets were washed twice with 4 mls of 
Chelex Buffer (0.05 M Hepes, 0.05 M NaCl), suspended in 3 mls Chelex Buffer with 8 M 
Urea and incubated for 1 hour at room temperature. Cells were then lysed using the 
sonication method and centrifuged at 14,800 rpm for 30 minutes. Supernatant was then 
collected and used for ICP-MS analysis to determine metal content.   
3.6.2. Colorimetric Ferrozine Assay 
 W83 and V3128 strains from blood and BHI plates were prepared the same way 
as section 3.6.1. Ammonium ferrous sulfate was used as our standard. Standards of 
0.5, 1.0, 2 and 2.5 ppm were created from the ammonium ferrous sulfate stock solution. 
500 µL of each standard and sample was added to different spectrophotometric 
cuvettes followed by 50 µL of 0.01M Ferrozine (SIGMA) and 25 µL of 5M ammonium 
acetate. The OD of each sample was measured after 24 hours using mass 
spectrophotometer set at 562 nm.  
3.7 Protease Assay 
3.7.1. Bacterial Preparation 
 W83 and V3128 strains were grown on both blood plates and BHI plates. They 
were inoculated in 0.5 mls of BHI to an OD between 1-1.4 at 660 nm. Samples were 
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centrifuged at 8000 rpm for 10 minutes, supernatant was removed and pellets were 
suspended in 0.5 mls of PBS.  
3.7.2. Arginine-Specific Protease Assay 
 Tris-HCl, L-Cysteine (SIGMA®), CaCl2 (SIGMA®), TCEP Nα-Benzoyl-DL-
arginine 4-nitroanilide hydrochloride (BAPNA) (SIGMA®), W83 and V3128 samples and 
distilled water were mixed in VIS cuvettes as designated in Table 3. Reactions were 
done at 37oC and OD was measured at 405 nm after 30 minutes, 60 minutes, 90 
minutes and 180 minutes of incubation  
Table 3: Arginine-specific protease activity 
Arginine-specific activity  
Reagent Concentration Volume 
Tris-HCl, pH 7.5 50 mM 400 µL 
L-Cysteine  500 mM 5 µL 
CaCl2 500 mM 5 µL 
TCEP 1 mM 5 µL 
BAPNA 0.0043 g/ml of dimethyl sulfoxide 
(DMSO) (SIGMA®) 
50 µL 
Sample  Approximately 25 µg 15-30 µL 
Water  30 µL 
 Total Volume = 500 µL 
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3.7.3. Lysine-Specific Protease Assay 
 Tris-HCl, L-Cysteine (SIGMA®), TCEP, Z-Lys-pNA (SIGMA®), W83 and V3128 
samples and distilled water were mixed in VIS cuvettes as designated by the Table 4. 
Reactions were done at 37oC and OD was measured at 405 nm after 30 minutes, 60 
minutes, 90 minutes and 180 minutes of incubation.  
Table 4: Lysine-specific protease activity 
Lysine-specific activity  
Reagent Concentration Volume 
Tris-HCl, pH 7.5 50 mM 400 µL 
L-Cysteine  500 mM 5 µL 
TCEP 1 mM 5 µL 
Z-Lys-pNA  0.0049 g/ml of dimethyl sulfoxide 
(DMSO) (SIGMA®) 
25 µL 
Sample  Approximately 25 µg 15-30 µL 
Water  60 µL 
 Total Volume = 500 µL 
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CHAPTER 4: RESULTS 
4.1 Identification of a putative TonB gene 
 PG0707 and PG0785 are designated as the same gene according to the Los 
Alamos and TIGR databases. BLAST was used to search the nucleotide and protein 
sequence of PG0785/0707 against the P. gingivalis W83 database. Results of the 
nucleotide sequence are seen in Table 5. There were four genes found that had TonB 
related features. The nucleotide sequence of PG0785 had a 79% similarity to the 
sequence of Bacteriodes vulgates ATCC 8482, 78% similarity to Haliscomenobacter 
hydrossis DSM 1100, 77% similarity to Tannerella forsythia ATCC 43037 and 76% to 
Bacteriodes xylanisolvens XB1A. The results of the protein sequence similarities are 
seen on Table 6. The protein sequence of PG0785 had 33% similarity with Chain B of 
Btub:tonB complex, 32% similarity with Chain A of E. coli TonB, 32% similarity with 
Chain C of TonB in complex with FhuA outer membrane receptor and 31% similarity 
with Chain A of TonB2 of Vibrio anguillarum. 
Table 5: Nucleotide sequence similarities of PG0785 with other sequences 
Nucleotide Sequence  
 Similarity 
Bacteriodes vulgates ATCC 8482 
Feature – Outer membrane protein TonB 
79% 
Haliscomenobacter hydrossis DSM 1100 
Feature – TonB family protein 
78% 
Tannerella forsythia ATCC 43037 
Feature – TonB dependent receptor 
77% 
Bacteriodes xylanisolvens XB1A 
Feature – Outer membrane transport energization protein TonB 
76% 
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 Table 6: Protein sequence similarities of PG0785 with other sequences 
Protein Sequence  
 Similarity 
Chain B, Structure Of The Btub:Tonb Complex 33% 
Chain A, Solution Structure Of Escherichia coli TonB 32% 
Chain C, Crystal Structure Of TonB In Complex With FhuA, E. coli 
Outer Membrane Receptor For Ferrichrome 
32% 
Chain A, Molecular Characterization Of The TonB2 Protein From 
Vibrio anguillarum 
31% 
 
 The homology model of the C-terminal structure of PG0785 was attained using 
one to one threading by Phyre (Kelley and Sternburg, 2009). The protein sequence of 
PG0785 is 230 amino acids long. Amino acids 155-230 (75 AA’s) correlate to the C-
terminal region and were used to generate this structure. This structure can be seen on 
Figure 5. The C-terminal domain structure of E. coli TonB (1IHR) was attained from 
Protein Data Bank (PDB). C-terminal residues 164-239 (76 AA’s) were used to generate 
this structure. Chimera was used to generate an overlay of the homology model of C-
terminal domain of PG0785 and C-terminal domain of E. coli TonB. This structure can 
be seen in Figure 6.   
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Figure 5: Homology Model of the C-terminal Domain of PG0785. Amino acids 155-
230 (75 AA’s) correlating to the C-terminal sequence of PG0785 were used to create 
the homology model using Phyre. The blue portion of this model represents the N-
terminal region and the red portion represents the C-terminal region.  
 
Figure 6: Overlay of the C-terminal Domains of E. coli TonB (1IHR) and PG0785. 
The C-terminal domain of TonB from E. coli is represented by the red model. The blue 
model represents the homology model of the C-terminal domain of PG0785. The 
overlay was made using the Chimera software.  
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4.2 Mutant Generation 
 In order to be able to determine the role of TonB in P. gingivalis our first aim was 
to generate a putative TonB deficient mutant. PG0785 is believed to be a possible TonB 
protein. A previous student in Dr. Lewis’ lab cloned PG0785, PG1912 and PG1913 into 
a pCR2.1 TA vector. Using restriction enzymes, an ErmF-AM cassette was inserted in 
the middle of the PG0785, PG1912 and PG1913 gene to disrupt their function. We will 
refer to these plasmids as pCR2.1PG0785, pCR2.1PG1912 and pCR2.1PG1913. PCR 
was done on the pCR2.10785 plasmid using primers for PG0785 and then analyzed by 
1% agarose gel to determine the size of the fragment (Figure 7).  pCR2.1PG1913, 
pCR2.1PG1912 and pCR2.1PG0785 plasmids were electroporated into P. gingivalis 
W83 (W83) electroporation cells and spread on blood plates with clindamycin. They 
were then grown at 37oC in an anaerobic chamber until colonies appeared. Colonies 
were then picked, screened using PCR and analyzed by 1% agarose gel 
electrophoresis. Figures 6, 7 and 8 show the results of our PCR products. Blood plates 
containing colonies for pCR2.1PG1913 + W83 (Figure 8) and pCR2.1PG1912 + W83 
(Figure 9) did not have a fragment at 3 kb meaning that the PG1913 + ErmF-AM 
cassette construct and PG1912 + ErmF-AM cassette construct were not inserted in the 
genome of W83. PCR was done on a colony picked from a blood plate containing 
pCR2.1PG0785 + W83 (Figure 10). Figure 10 shows the electrophoresis gel done on 
the PCR product. A 3 kb fragment can be seen in lane 3 meaning that the PG0785 + 
ErmF-AM cassette was successfully inserted the genome of W83. In lane 3 there are 
two specific bands at 3 kb and around 1 kb. This means that this was most likely a 
double crossover event meaning that part of t the intact gene has remained. If there was 
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only one band at 3 kb in lane 3 then it would suggest a single crossover event had 
taken place.  
                              
Figure 7: Restriction enzyme profile of pCR2.1PG0785 plasmid PCR products. The 
construct consisting of the ErmF-AM cassette and surrounding PG0785 was amplified 
by PCR. Lane 1: Ladder; Lane 2: pCR2.1PG0785 plasmid 1:10 dilution; Lane 3: 
pCR2.1PG0785 plasmid 1:100 dilution; Lane 3: Genomic DNA. Both pCR2.1PG0785 
dilutions had a fragment at 3 kb compared to the genomic DNA which did not have a 
fragment at 3 kb. This suggests that any mutant that has the construct successfully 
inserted in its genome should have the same 3 kb fragment.  
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Figure 8: Restriction enzyme profile of the PCR product of selected 
pCR2.1PG1913 + W83 colonies. Selected colonies were used as template and 
amplified by PCR. PCR products were analyzed by gel electrophoresis. Lane 1: Ladder; 
Lane 2: pCR2.1PG1913 + V2802 W83; Lane 3: pCR2.1PG1913 + V2984 W83; Lane 4: 
pCR2.1PG1913 + V2984 W83; Lane 5: pCR2.1PG1913 + V2802 W83; Lane 6: 
pCR2.1PG1913 + V2984 W83; Lane 7: pCR2.1PG1913 + V2984 W83; Lane 8: 
Genomic DNA. Lanes 2-7 represent the PCR product of selected pCR2.1PG1913 + 
W83 colonies from blood plates. None of the colonies selected had a fragment at 3 kb 
(white box) meaning that the construct was not inserted into the genome of W83.   
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Figure 9: Restriction enzyme profile of the PCR product of selected 
pCR2.1PG1912 + W83 colonies. Selected colonies were used as template and 
amplified by PCR. PCR products were analyzed by gel electrophoresis. Lane 1: Ladder; 
Lane 2: pCR2.1PG1912 + 2984 W83; Lane 3: pCR2.1PG1912 + 2984 W83; Lane 4: 
pCR2.1PG1912 + 2984 W83; Lane 5: pCR2.1PG1912 + 2984 W83; Lane 6: Genomic 
DNA. Lanes 2-5 represent the PCR product of selected pCR2.1PG1912 plasmid + W83 
colonies from blood plates. None of the colonies selected had a fragment at 3 kb (white 
box) meaning the construct was not inserted into the genome of W83.    
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Figure 10: Restriction enzyme profile of the PCR product of selected 
pCR2.1PG0785 + W83 colony. Selected colonies were used as template and amplified 
by PCR. PCR products were analyzed by gel electrophoresis. Lane 1: Ladder; Lane 2: 
pCR2.1PG0785 + 2984 W83 on BP; Lane 3: pCR2.1PG0785 + 2984 W83 on BP + 
Clindamycin; Lane 4: Genomic DNA. Lane 3 represents the PCR product of 
pCR2.1PG0785 plasmid + W83 colony selected from blood plate. There is a fragment at 
3 kb (white box) suggesting that the construct consisting of PG0785 + the ErmF-AM 
cassette was inserted into the genome of W83.   
4.3 Mutant Growth  
 W83 grew well in BHI broth compared to the putative TonB deficient mutant 
(V3128) which did not grow in BHI broth. As a result both strains were repeatedly grown 
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on blood and BHI plates. The V3128 strain was always grown on blood and BHI plates 
containing clindamycin. Both W83 and V3128 strain grew well on blood plates. W83 
would usually become dark pigmented after a week on blood plates compared to V3128 
which never became dark pigmented on blood plates. W83 also grew well on BHI plates 
but never became dark pigmented. V3128 would usually not grow on BHI plates after 3 
times of re-plating. As a result, once V3128 on BHI plates stopped growing, V3128 from 
blood plates had to be used to again grow V3128 on BHI plates. Since V3128 did not 
grow in BHI broth we could not produce accurate growth curves. Based on their growth 
on blood plates, usually after 6-7 hours both strains would start to grow on both blood 
and BHI plates. After 24 hours both strains would grow enough to be ready to use for 
experiments. Figure 11 shows W83 and V3128 on blood and BHI plates.  
    
Figure 11: Blood plates containing W83 and V3128. W83 and V3128 were grown 
anaerobically on blood plates at 37o C for 7 days. (A) Blood plate containing W83. (B) 
Blood plate containing V3128.    
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4.4 Eukaryotic Cell Invasion and Total Interaction 
4.4.1. Total Interaction and Invasion Assay 
 We wanted to find out how virulence of V3128 would be affected compared to 
W83. To do so we performed total interaction and invasion assays to see how V3128 
interacts and invades eukaryotic cells. W83, V3128 and HUVEC cells were prepared as 
indicated in the “Materials and Methods” section. For the total interaction assay, 
bacteria were incubated with HUVEC cells and cultures were then spread on blood 
plates from the undiluted tubes, 1:10 dilution tubes and 1:100 dilution tubes. For the 
invasion assay, bacteria were incubated with HUVEC cells and antibiotics were then 
added to kill any extracellular bacteria so that only bacteria that had invaded the 
HUVEC cells would be able to grow. Cultures were then spread on blood plates from 
the undiluted tubes, 1:10 dilution tubes and 1:100 dilution tubes. Colonies were counted 
after 1-2 weeks.  
Figure 12 shows plates that contained colonies for the total interaction assay and 
Figure 13 shows plates that contained colonies for the invasion assay. Four biological 
repeats were done and the number of colonies from each experiment was averaged 
together. Results of the total interaction assay are shown on Figure 14. For the total 
interaction assay, W83 from undiluted tubes had an average of 1556 colonies compared 
to V3128 from undiluted tubes which had an average of 23 colonies. W83 from 1:10 
dilution tubes had an average of 552 colonies compared to V3128 from 1:10 dilution 
which had an average of 181 colonies. W83 from 1:100 dilutions had an average of 88 
colonies compared to V3128 from 1:100 dilutions which had an average of 73 colonies. 
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These results show that W83 interacts with HUVEC cells at significantly higher levels 
than V3128.   
Results of the invasion assay are shown in Figure 15. For invasion assay, W83 
from undiluted tubes had an average of 1366 colonies compared to V3128 from 
undiluted tubes which had an average of 142 colonies. W83 from 1:10 dilutions had an 
average of 511 colonies compared to V3128 from 1:10 dilutions which had an average 
of 29 colonies. W83 from 1:100 dilutions had an average of 68 colonies compared to 
V3128 from 1:100 dilutions which had an average of 5 colonies. These results show that 
W83 has significantly higher ability to invade eukaryotic cells than V3128.  
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Figure 12: Blood plates containing colonies for the total interaction assay. 
Cultures from undiluted tubes, 1:10 dilution tubes and 1:100 dilution tubes were spread 
on blood plates and colonies were counted after 1 week. W83 from undiluted tubes (A), 
W83 from 1:10 dilution tubes (B), W83 from 1:100 dilution tubes (C), V3128 from 
undiluted tubes (D), V3128 from 1:10 dilution tubes (E) and V3128 from 1:100 dilution 
tubes (F). 
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Figure 13: Blood plates containing colonies for the invasion assay. Cultures from 
undiluted tubes, 1:10 dilution tubes and 1:100 dilution tubes were spread on blood 
plates and colonies were counted after 1 week. W83 from undiluted tubes (A), W83 
from 1:10 dilution tubes (B), W83 from 1:100 dilution tubes (C), V3128 from undiluted 
tubes (D), V3128 from 1:10 dilution tubes (E) and V3128 from 1:100 dilution tubes (F). 
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Figure 14: Total Interaction Assay for V3128 and W83 strains. W83 and V3128 were 
inoculated with HUVEC cells in 6 well plates. Cultures were spread on blood plates from 
undiluted tube, 1:10 dilution and 1:100 dilution and colonies were counted after one 
week. Yellow bars represent W83 from blood plates and black bars represent V3128 
from blood plates. The average number of colonies from each plate is represented by 
the Y-axis.  
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Figure 15: Invasion Assay of V3128 and W83 strains. W83 and V3128 were 
inoculated with HUVEC cells in 6 well plates. Antibiotics were added to kill extracellular 
bacteria so that only bacteria that had invaded HUVEC cells could survive. Cultures 
were spread on blood plates from undiluted tube, 1:10 dilution and 1:100 dilution and 
colonies were counted after one week. Yellow bars represent W83 from blood plates 
and black bars represent V3128 from blood plates. The number of colonies is 
represented by the Y-axis.  
4.4.2. Flow Cytometry 
 Flow cytometry was done on both V3128 and W83 for total interaction and 
invasion. Four biological repeats were done and the median fluorescence (MF) of each 
experiment was averaged together. Results can be seen in Figure 16. V3128 had an 
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MF of 202 for total interaction and an MF of 195.75 for invasion. W83 had an MF of 
180.5 for total interaction and an MF of 170.5 for invasion.   
              
Figure 16: Flow cytometry results for total interaction and invasion. V3128 and 
W83 were labeled with FITC. They were then inoculated with HUVEC cells. Yellow bars 
represent the total interaction by V3128 and W83. Blue bars represent invasion by 
V3128 and W83. The Y-axis represents the median fluorescence measured.  
4.5 Proteomics  
 Proteomics was done on both W83 and V3128 strains to identify major proteins 
up-regulated and down-regulated. Bands were excised out of gel and send for analysis. 
Figure 17 shows the bands that were excised out of the gel. The samples were 
analyzed using the Sequest search algorithm against P. gingivalis database. Figure 18 
shows the peptides and proteins that were identified from the gel slices. The major 
proteins identified were lipoprotein RagB (ragB) represented by band 6 in Figure 17, 
RagA protein (ragA) represented by band 1, 4-hydroxybutyryl-CoA dehydratase (abfD) 
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represented by band 5, hemmagglutinin proteins HagA and HagE represented by bands 
9 and 10, outer membrane lipoprotein Omp28 (omp28), immunoreactive 43 kDa antigen 
PG32 represented by band 14, ABC transporter ATP-binding protein represented by 
band 12, glutamate dehydrogenase, NAD-specific (GDH), arginine-specific cysteine 
proteinase (PrtRII) and Dps family protein.  
                                      
Figure 17: V3128 and W83 proteomic products ran on protein gel. Lane 1: Ladder; 
Lane 2: V3128 from blood plate; Lane 3: W83 from blood plate. Bands 1, 5, 6, 9, 12 and 
14 from V3128 and bands 1, 5, 6, 9, 19 and 14 from W83 were excised out of gel and 
sent for analysis to identify proteins from the gel.  
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Figure 18: Peptides and proteins identified from gel slices using Sequest search 
algorithm. Gel slices were analyzed using the sequest search algorithm to identify 
proteins.The major proteins identified were lipoprotein RagB (RagB), RagA protein 
(RagA), 4-hydroxybutyryl-CoA dehydratase (AbfD), hemagglutinin protein HagA and 
HagE, outer membrane lipoprotein Omp28 (Omp28), immunoreactive 43 kDa antigen 
PG32, ABC transporter ATP-binding protein, NAD-specific glutamate dehydrogenase  
(GDH), arginine-specific cysteine proteinase (PrtRII) and a Dps family protein.  
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4.6 RNA Library Generation 
 W83 and V3128 RNA were isolated and used to generate RNA libraries as 
described in the “Materials and Methods” section. Three sets of libraries were generated 
on different dates. Samples were then sent to the VCU Sanger Hall sequencing center 
to be validated and sequenced.  
4.6.1 Validation of the RNA-Seq Library using the BioAnalyzer 
  The bioanalyzer results for our samples are shown in Figures 19, 20, 21, 22 and 
23. The results indicated that the RNA libraries were ready for processing and 
sequencing since all of the samples had peaks less than 1000 base pairs.  
                       
Figure 19: Electropherogram results from bioanalyzer of V3128 and W83 RNA 
from 3/06/2014.   
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Figure 20: Electropherogram results from bioanalyzer of W83 RNA from 
04/10/2014 
 
Figure 21: Electropherogram results from bioanalyzer of V3128 RNA from 
04/10/2014  
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Figure 22: Electropherogram results from bioanalyzer of W83 RNA from 
04/14/2014 
 
Figure 23: Electropherogram results from bioanalyzer of V3128 RNA from 
04/14/2014 
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4.6.2. High throughput sequencing of RNA libraries 
The samples were sequenced using Rapid flow cell (VCU Sanger Hall). From the 
high throughput sequencing results, we were able to align the DNA fragments along the 
P. gingivalis genome. Across the whole genome were areas of high copy numbers 
which can be seen in Figure 24. 
    
Figure 24: High throughput sequencing reads aligned with P. gingivalis W83 
genome. The y-axis represents the number of reads and the x-axis represents the 
region of the genome.  
4.6.3. Statistical Analysis 
 We performed statistical analysis of our transcriptomic results by looking at the 
reads and fold changes of the genes. Figure 25 shows that 16s rRNA had the highest 
reads recorded. By looking at the fold changes we were able to determine which genes 
had been up-regulated and down-regulated in V3128 compared to W83. Table 7 lists 
the number of genes regulated from RNA samples prepared on 3/06/14. Table 8 lists 
the number of genes which were up-regulated and down-regulated in RNA samples 
from 4/10/2014.  Table 9 lists the number of genes which were up-regulated and down-
regulated in RNA samples from 4/14/2014. Figure 26 shows the most down-regulated 
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and up-regulated genes from RNA samples prepared on 3/06/2014. These include 
PG1511, PG0337, PG1710, PG0711, PG0835, PG1167, PG2104, PG2224, PG0043, 
PG0042, PG0787 and PG1234. Figure 27 shows the most down-regulated and up-
regulated genes from RNA samples prepared on 4/10/2014.  Some of the most down-
regulated genes include PG1310, PG0717, PG1312, PG1109, PG1858, PG0566, 
PG1522, PG1690, PG1498, PG1311, atpK, PG0785. Some of the up-regulated genes 
include rpsR, PG0326, PG0065, PG0302, PG0071, lpxA, PG0069, PG0223, lpxB, 
PG0086, abfT-1, PG0475. Figure 28 shows the most down-regulated and up-regulated 
genes from RNA samples prepared on 4/14/2014. Some of the most down-regulated 
genes include PG0785, PG1779, PG0439, murC, PG0059, PG0843, radC, PG2006, 
PG1407, uraA, PG1042, PG1667. Some of the most up-regulate genes include rpsR, 
PG1528, PG0217, PG0327, ngrC, fabF, PG1156, PG0430, lpxB, uvrB, PG1954, 
PG0133. The variability in expression of the genes seen in figure 26, 27 and 28 could 
be due to the fact that each time V3128 grows somewhat differently each time it is 
grown on a new plate. We were interested to see how TonB-related genes, metal 
regulation genes, hemin regulation genes and genes involved in virulence of P. 
gingivalis were regulated in V3128 compared to W83.  
Table 10 lists genes of interest that were down-regulated and up-regulated. 
PG0785, which is our putative TonB gene, was down-regulated in all three samples. 
PG0707, PG0668, PG1899 and PG2008 are all putative TonB dependent receptors 
which are down-regulated in two of the three sequencing samples. hmuR, hmuY and tlr 
are genes involved in hemin binding on surface of P. gingivalis and they were down-
regulated in all three samples with the exception of hmuR which was up-regulated in 
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RNA sequencing sample from 4/14/2014. Pg0646, PG0647, PG0648, PG0671, PG0672 
are all genes involved in the iron ABC transporter which is crucial for uptake of iron in P. 
gingivalis. These genes have been down-regulated in two of the three sequences and 
up-regulated in one of the sequences. RagA is also involved in iron uptake and it has 
been down-regulated in two of the three sequences. PG1312 is believed to be a capA 
gene involved in capsulation of P. gingivalis. It was slightly down-regulated in RNA 
sample from 3/06/14, significantly down-regulated in RNA sequence from 4/10/14 (3rd 
most down-regulated gene) and slightly up-regulated in RNA sequence from 4/14/2014. 
PG1975, PG1837 and PG1972 are all hemagglutinin genes which are involved in 
adherence of the bacteria with epithelial cells which is important for the virulence of P. 
gingivalis. PG1975 is down-regulated in all three sequences, PG1837 is down-regulated 
in two of the three sequences and PG1972 is also down-regulated in two of the three 
sequences. The arginine-specific protease (prtRII) gene was slightly up-regulated in two 
of the sequences and significantly down-regulated in the other sequence. 
      
Figure 25: All sequence reads aligned to P. gingivalis W83 genome. The y-axis 
represents the intensity of individual reads and x-axis represents regions of the 
genome. The selected region in this figure shows that the16s rRNA intensities are the 
four largest peaks.  
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Table 7: Number of genes up-regulated and down-regulated from samples 
prepared on 3/06/2014 
Number of down-regulated genes  Fold Change 
172 Between 1.5 – 1.9 
605 Between 1.2 - 1.5 
483 Between 1 – 1.2 
Number of up-regulated genes Fold Change 
13 >2 fold 
53 Between 1.5 – 2 
592 Between 1 – 1.5 
 
Table 8: Number of genes up-regulated and down-regulated from samples 
prepared on 4/10/2014 
Number of down-regulated genes  Fold Change 
28  >20 fold 
58 Between 10 – 20 
157 Between 5 – 10 
446 Between 2 – 5 
742  Between 0.5 – 2 
Number of up-regulated genes Fold Change 
224 Between 0.5 – 2 
17 Between 2-14 
 
Table 9: Number of genes up-regulated and down-regulated from samples 
prepared on 4/14/2014 
Number of down-regulated genes  Fold Change 
21 Between 2-10 
287 Between 0.5-2 
Number of up-regulated genes Fold Change 
514 Between 0.5-1 
496 Between 1-2 
291 Between 2-5 
31 Between 5-10 
11 >10  
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Figure 26: Genes up-regulated and down-regulated from RNA samples 
(3/06/2014). * “A” depicts the most down-regulated genes in V3128 compared to W83 
while “B” depicts the most up-regulated genes in V3128 compared to W83. (1) Gene 
identification in P. gingivalis. (2) The fold change is comparing the RPKM values of 
V3128 to W83. (3) RPKM: the reads by kilobase transcript per million reads is reflective 
of the number of reads fo each respective gene in W83. (4) RPKM: the reads by 
kilobase transcript per million reads is reflective of the number of reads of each 
respective gene in V3128.  
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Figure 27: Genes up-regulated and down-regulated from RNA samples 
(4/10/2014). * “A” depicts the most down-regulated genes in V3128 compared to W83 
while “B” depicts the most up-regulated genes in V3128 compared to W83. (1) Gene 
identification in P. gingivalis. (2) The fold change is comparing the RPKM values of 
V3128 to W83. (3) RPKM: the reads by kilobase transcript per million reads is reflective 
of the number of reads for each respective gene in W83. (4) RPKM: the reads by 
kilobase transcript per million reads is reflective of the number of reads of each 
respective gene in V3128. 
 63 
 
 
Figure 28: Genes up-regulated and down-regulated from RNA samples 
(4/14/2014). * “A” depicts the most down-regulated genes in V3128 compared to W83 
while “B” depicts the most up-regulated genes in V3128 compared to W83. (1) Gene 
identification in P. gingivalis. (2) The fold change is comparing the RPKM values of 
V3128 to W83. (3) RPKM: the reads by kilobase transcript per million reads is reflective 
of the number of reads for each respective gene in W83. (4) RPKM: the reads by 
kilobase transcript per million reads is reflective of the number of reads of each 
respective gene in V3128. 
 
 64 
 
Table 10: Genes of interest from three biological replicates 
RNA Sequencing  
 Fold Change (3) 
Gene 
ID (1) 
Description (2) RNA 
from 
3/06/14 
RNA 
from 
4/10/14 
RNA 
from 
4/14/14 
PG0785 TonB protein, putative -1.37 -47.78 -16.50 
PG0707 TonB-dependent receptor, putative -1.57 -2.23 1.32 
PG0668 TonB-dependent receptor -1.16 -1.83 2.96 
PG1899 TonB-dependent receptor, putative -1.10 -2.92 2.22 
PG2008 TonB-dependent receptor, putative -1.43 -1.83 1.88 
hmuR TonB-dependent receptor HmuR -1.03 -5.32 1.93 
hmuY HmuY protein -1.14 -5.20 -2.30 
Tlr TonB-linked hemin receptor Tlr -1.60 -6.17 -1.43 
PG1875 Hemolysin -1.47 -9.27 -1.28 
PG0646 Iron compound ABC transporter, ATP-binding 
protein 
-1.42 -4.20 2.68 
PG0647 Iron compound ABC transporter, permease 
protein 
-1.23 -4.99 2.34 
PG0648 Iron compound ABC transporter, periplasmic 
iron compound-binding protein, putative 
1.06 -3.75 1.56 
PG0671 Iron compound ABC transporter, permease 
protein 
-1.49 -4.00 1.34 
PG0672 Iron compound ABC transporter, ATP-binding 
protein 
-1.51 -3.25 1.23 
Raga RagA protein -1.31 -1.56 1.6 
PG1312 CapA protein -1.41 -80.64 1.17 
PG1975 Hemagglutinin, HagC -1.42 -42.05 -1.76 
PG1837 Hemagglutinin, HagA 1.38 -4.97 -2.13 
PG1972 Hemagglutinin, HagB -1.03 -2.37 2.16 
prtRII Arginine-specific cysteine protease  1.07 -11.29 1.60 
 
* This table contains our genes of interest. (1) Gene identification obtained from NCBI. 
(2) Description of the respective gene. (3) Fold changes of all three RNA sequencing 
samples. It compares the RPKM values of V3128 to W83.The fold change values tell us 
if our genes of interest have been up-regulated or down-regulated in V3128 compared 
to W83.  
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4.7 Metal Content Assay 
To determine if PG0785 played a role in metal regulation, we performed metal 
content assays on both W83 and V3128. W83 and V3128 strains from blood and BHI 
plates were prepared as indicated in the “Materials and Methods” section. 
4.7.1 Metal Content using ICP-MS Analysis 
 Samples were analyzed by using an ICP-MS to determine the amount of iron 
(Fe), magnesium (Mg), manganese (Mn), zinc (Zn), nickel (Ni), copper (Cu) and cobalt 
(Co) in each sample. Metal content results for Ni, Cu, Zn and Co are shown on Figure 
29 and results for Fe, Mg and Mn are shown on Figure 30. For Ni, W83 from blood plate 
had a ppt of 27,706 compared to V3128 from blood plate which had a ppt of 33,219. 
W83 from BHI plate had a ppt of 30,146 compared to V3128 from BHI plate which had a 
ppt of 33,549. For Cu, W83 from blood plate had a ppt of 37,483 compared to V3128 
from blood plate which had a ppt of 22,106. W83 from BHI plate had a ppt of 69,501 
compared to V3128 from BHI plate which had a ppt of 46,020. For Zn, W83 from blood 
plate had a ppt of 68,643 compared to V3128 from blood plate which had a ppt of 
140,527. W83 from BHI plate had a ppt of 72,208 compared to V3128 from BHI plate 
which had a ppt of 82,752. For Co, W83 from blood plate had a ppt of 6,434 compared 
to V3128 from blood plate which had a ppt of 7,401. W83 from BHI plate had a ppt of 
15,582 compared to V3128 from BHI plate which had a ppt of 53,706. These results 
indicated that there was not a significant difference between V3128 and W83 in uptake 
of Ni, Cu, Zn and Co. In fact, V3128 had higher values for these metals than W83.  
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For Mg, W83 from blood plates had a PPT of 3,079,268 compared to V3128 from 
blood plates which had 743,942. W83 from BHI plates had a ppt of 1,210,178 compared 
to V3128 which had a ppt of 425,705. For Mn, W83 from blood plate had a ppt of 
372,233 compared to V3128 from blood plate which had a ppt of 86,091. W83 from BHI 
plate had a ppt of 150,636 compared to V3128 from BHI plate which had a ppt of 
161,591. For Fe, W83 from blood plate had a ppt of 3,395,185 compared to V3128 from 
blood plate which had a ppt of 164,824. W83 from BHI plate had a ppt of 137,910 
compared to V3128 from BHI plate which had a ppt of 203,222. These results indicate 
that W83 had significantly higher values of Fe, Mn and Mg than V3128 suggesting that 
PG0785 could play a major role in uptake of these metals.       
 
Figure 29: Ni, Cu, Zn and Co content of V3128 and W83 metals measured. Samples 
were analyzed using ICP-MS. Blue bars represent V3128 from BHI, green bars 
represent W83 from BHI, Red bars represent V3128 from BP and purple bars represent 
W83 from BP. Metal concentrations are in parts per trillion (PPT) 
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Figure 30: Fe, Mn and Mg content of V3128 and W83. Samples were analyzed using 
ICP-MS. Blue bars represent V3128 from BHI, green bars represent W83 from BHI, Red 
bars represent V3128 from BP and purple bars represent W83 from BP. Metal 
concentrations are in parts per trillion (PPT). 
4.7.2 Metal Content using Ferrozine Assay 
 The ICP-MS we were using had major maintenance issues and as a result we 
decided to perform ferrozine assay as an alternative method for quantifying the Fe 
concentration in our samples. Samples were prepared using the same protocol as 
samples for ICP-MS analysis. Samples were then treated with Ferrozine which interacts 
with ferrous iron and forms a purple colored solution. The absorbance was measured at 
562 nm using a mass spectrophotometer. Five sets of experiments were done with 
freshly prepared samples. The absorbance of the four standards (0.5 ppm = 0.87, 1 
ppm = 0.198, 2 ppm = 0.398 and 2.5 ppm = 0.490) were measured and used to make a 
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scatter plot (Figure 31). The plot gave us an R2 = 0.997 and an equation set at y = 
0.2101x. This equation was used to determine the Fe concentration of our samples. 
Table 11 shows the concentration of Fe from each sample in ppm. The results show 
that there was no significant difference in Fe concentration between V3128 and W83.  
        
Figure 31: Plot of standards. Ferrozine was added to the standards and the 
absorbance of each standard was measured at 562 nm. The y-axis represents the 
absorbance of the standards. The plot gave us an R2 value of 0.9972 and an equation 
set at y = 0.2101x. This equation was used to determine the Fe concentration of our 
samples.  
Table 11: Concentration of Fe from V3128 and W83 using the ferrozine assay 
Bacterial Samples(1) Absorbance (562 nm)(2) Concentration (PPM) of Fe(3) 
V3128 from blood plate 0.1430 0.6803 
W83 from blood plate 0.1462 0.6960 
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V3128 from BHI plate 0.1431 0.6808 
W83 from BHI plate 0.0847 0.4029 
 
* (1) Indicates the bacterial samples used. (2) The absorbance measurements of our 
bacterial samples. (3) The Fe concentrations of the bacterial samples.  
4.8 Protease Assay 
 Protease assays were done to see if PG0785 could play a role in protease 
activity. Three biological repeats of the protease assay were done for W83 and V3128 
strains grown on blood and BHI plates. The absorbance at 405 nm for each experiment 
was measured at 30, 60, 90 and 180 minutes. The results for all three experiments were 
averaged together. The absorbance for the arginine protease activity of W83 from blood 
plates had an average of 0.88 at 30 minutes, 1.27 at 60 minutes, 1.99 at 90 minutes 
and 2.7 at 180 minutes. The absorbance of V3128 from blood plates was 0.252 at 30 
minutes, 0.321 at 60 minutes, 0.371 at 90 minutes and 0.475 at 180 minutes. Figure 32 
shows a plot of the arginine protease activity for W83 and V3128 strains from blood 
plates. The absorbance of W83 from BHI plates was 1.47 at 30 minutes, 2.46 at 60 
minutes, 2.99 at 90 minutes and 3.40 at 180 minutes. The absorbance of V3128 from 
BHI plates was 0.239 at 30 minutes, 0.293 at 60 minutes, 0.356 at 90 minutes and 
0.437 at 180 minutes. Figure 33 shows a plot of the arginine protease activity for W83 
and V3128 strains from BHI plates. These results showed that W83 from both blood and 
BHI plates had significantly higher arginine-specific protease activity than V3128.   
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The absorbance for the lysine protease activity of W83 from blood plates was 
0.421 at 30 minutes, 0.733 at 60 minutes, 0.923 at 90 minutes and 1.540 at 180 
minutes. The absorbance for the V3128 from blood plates was 0.180 at 30 minutes, 
0.236 at 60 minutes, 0.300 at 90 minutes and 0.470 at 180 minutes. Figure 34 shows 
the plot of the lysine protease activity for W83 and V3128 strains from blood plates. The 
absorbance for the W83 from BHI plates was 0.561 at 30 minutes, 0.993 at 60 minutes, 
1.272 at 90 minutes and 2.005 at 180 minutes. The absorbance for V3128 was 0.180 at 
30 minutes, 0.231 at 60 minutes, 0.274 at 90 minutes and 0.415 at 180 minutes. Figure 
35 shows the plot of the lysine protease activity for W83 and V3128 from BHI plates. 
These results indicate that W83 from both blood and BHI plates has significantly higher 
lysine-specific protease activity than V3128.  
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Figure 32: Arginine protease activity of W83 and V3128 grown on blood plates. 
V3128 and W83 from blood plates were prepared as indicated in the “Materials and 
Methods” section. BAPNA was added to each sample and absorbance was measured 
at 405 nm at 30, 60, 90 and 180 minutes. The red squares represent W83 from blood 
plates and blue diamonds represent V3128 from blood plates. The x-axis represent the 
time in minutes of the absorbance recordings. The y-axis represents the activity of 
proteases by monitoring absorbance at 405 nm.  
y = -2E-05x2 + 0.0059x + 0.0337 
R² = 0.9528 
y = -7E-05x2 + 0.0273x + 0.0256 
R² = 0.9908 
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
0 30 60 90 120 150 180 210 
A
b
so
rb
an
ce
 a
t 
4
0
5
 n
m
 
TIme (Minutes) 
Arginine Protease Activity - BP 
V3128 
W83 
 72 
 
 
Figure 33: Arginine protease activity of W83 and V3128 grown on BHI plates. 
V3128 and W83 from blood plates were prepared as indicated in the “Materials and 
Methods” section. BAPNA was added to each sample and absorbance was measured 
at 405 nm at 30, 60, 90 and 180 minutes. The red squares represent W83 from blood 
plates and blue diamonds represent V3128 from blood plates. The x-axis represent the 
time in minutes of the absorbance recordings. The y-axis represents the activity of 
proteases by monitoring absorbance at 405 nm. 
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Figure 34: Lysine protease activity of W83 and V3128 grown on blood plates. 
V3128 and W83 from blood plates were prepared as indicated in the “Materials and 
Methods” section. Z-Lys-pNA was added to each sample and absorbance was 
measured at 405 nm at 30, 60, 90 and 180 minutes. The red squares represent W83 
from blood plates and blue diamonds represent V3128 from blood plates. The x-axis 
represent the time in minutes of the absorbance recordings. The y-axis represents the 
activity of proteases by monitoring absorbance at 405 nm. 
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Figure 35: Lysine protease activity of W83 and V3128 grown on BHI plates. V3128 
and W83 from blood plates were prepared as indicated in the “Materials and Methods” 
section. Z-Lys-pNA was added to each sample and absorbance was measured at 405 
nm at 30, 60, 90 and 180 minutes. The red squares represent W83 from blood plates 
and blue diamonds represent V3128 from blood plates. The x-axis represent the time in 
minutes of the absorbance recordings. The y-axis represents the activity of proteases 
by monitoring absorbance at 405 nm. 
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CHAPTER 5: DISCUSSION 
 Iron uptake is vital for bacterial survival inside the host. P. gingivalis is one of the 
main etiological agents involved in initiation and progression of periodontal disease. P. 
gingivalis survival inside the periodontal pocket relies on its ability to take up iron in the 
form of hemin which it does by proteolytic breakdown of hemin containing proteins. The 
TonB/ExbB/ExbD is believed to play a major role in uptake of hemin. However, currently 
nothing is known the role and mechanism of TonB in P. gingivalis. As a result we 
generated a putative TonB deficient P. gingivalis mutant to further investigate the role of 
TonB in P. gingivalis.  
 Using bioinformatics, our lab identified two genes, PG0785/0707 and PG1912 
that were further investigated as putative TonB genes. BLAST results for PG0785 
showed that the nucleotide sequence of this gene had sequence similarities to four 
other genes that had TonB related features (Table 5). BLAST analysis also showed that 
the protein sequences of PG0785 had 33% similarity with Chain B of Btub:tonB 
complex, 32% similarity with Chain A of E. coli TonB, 32% similarity with Chain C of 
TonB in complex with FhuA outer membrane receptor and 31% similarity with Chain A 
of TonB2 of Vibrio anguillarum (Table 6). We also generated a homology model for 
PG0785 (Figure 5) using one to one threading by Phyre. We then used chimera to 
overlay this homology model of PG0785 with Chain A of C-terminal domain of E. coli 
TonB (Figure 6). There were some minor differences between the structures but overall 
they showed very strong similarities with each other. All of the bioinformatics information 
led us to believe that PG0785 would be a good candidate to further investigate as a 
possible P. gingivalis TonB protein.  
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 In order to test our hypothesis, we first aimed to generate a P. gingivalis mutant 
that had a disrupted PG0785 gene. We were provided pCR2.1PG0785 plasmid which 
had a non-functional PG0785 gene + ErmF-AM cassette construct. PCR was first done 
on pCR2.1PG0785 plasmid to determine the size of the construct. Lanes 2 and 3 in 
Figure 7 show that the construct had a fragment at 3 kb when ran on 1% agarose gel. 
We expected that successful transformation would yield mutants that would have the 
same size 3 kb fragment. We used electroporation to try and transform pCR2.1PG0785 
into wild type P. gingivalis W83 (W83) cells. Selected colonies were screened using 
PCR and ran on 1% agarose gel. Lane 3 in Figure 10 shows that a pCR2.1PG0785 + 
W83 colony selected from a blood plate had a 3 kb fragment suggesting that the 
PG0785 + ErmF-AM cassette construct had been inserted into the W83 genome and we 
had successfully generated a P. gingivalis mutant that had a non-functioning PG0785 
gene. We refer to this mutant as V3128. We were never able to generate a P. gingivalis 
mutant that had PG1912 knocked out.  
There were significant differences between the phenotype of W83 and V3128 
when grown on blood and BHI plates. One of the key characteristics of P. gingivalis is 
its ability to become dark pigmented on blood plates due to accumulation of hemin on 
its surface. When grown on blood plates, our W83 became dark pigmented after one 
week on blood plates (Figure 11). However, V3128 never became dark pigmented on 
blood plates meaning that hemin could not accumulate on its surface (Figure 9). This 
suggested that PG0785 could potentially play a pivotal role in binding of hemin to the 
surface of P. ginigvalis.  
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Our second aim was to determine the metal content of V3128 to determine 
whether PG0785 plays role in metal uptake. Multiple studies have suggested that TonB 
is involved in uptake of hemin which is critical for growth of bacteria. We performed 
comparative metal content assays between W83 and V3128. We grew both strains on 
blood and BHI plates and used an ICP-MS to quantify the amount of metal in each 
sample. We expect our wild type strain to contain significantly higher levels of iron then 
the mutant strain. Figure 29 shows the content for Ni, Cu, Zn and Co. We can see that 
in W83 there was not a significant increase in any of these metals compared to the 
mutant. In fact V3128 had elevated levels of Ni, Zn and Co. Figure 30 shows the results 
for Mg, Mn and Fe. W83 had significantly higher concentrations of Mg and Mn 
compared to V3128. But more importantly, Fe levels were significantly higher in W83 
from blood plates than V3128 from blood plates. In fact W83 had an iron content of 
3,395,185 which was the highest recorded metal.  
P. gingivalis acquires iron in the form of hemin. Our results showed that V3128 
contains significantly less iron but we cannot make the assumption that V3128 also has 
significantly less hemin levels until we perform hemin uptake analysis. Based on these 
results we can see that PG0785 potentially plays an important role in iron uptake since 
V3128 has significantly less iron concentration than W83. Unfortunately the ICP-MS we 
were using became damaged and as a result we were only able to perform one metal 
content assay using ICP-MS.  
We decided to perform colorimetric ferrozine assays to further analyze the Fe 
content of our samples. We expected W83 from blood plates to have the highest 
absorbance and concentration. Table 11 shows the results of our ferrozine assays. We 
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can see that W83 from blood plate had very similar Fe concentration to V3128. One 
reason could be the method that we used to prepare our samples. The protocol we 
were using for the ferrozine assay did not indicate how to prepare samples. As a result 
we prepared our samples for the ferrozine assay just like we did for ICP-MS. This might 
not have been a suitable way of preparing the samples, especially since it took about 24 
hours for the color change compared to the 10 minutes that was indicated in the 
protocol. We also realized that our results from the ferrozine assay were not useful 
because this assay measured the ferric iron levels. However, we were interested in the 
ferrous iron levels because that is the form of iron that P. gingivalis requires for its 
growth. In order to get useful results, this ferrozine assay needs to be done in an 
anaerobic chamber.  
Our third aim was to determine the protease activity of V3128 and W83. Protease 
assays were done to compare the arginine-specific and lysine-specifc cysteine protease 
activity of both V3128 and W83. The results of the three experiments were averaged 
together and are shown in Figures 32, 33, 34 and 35. Figures 32 and 33 show that W83 
from both blood and BHI plates has significantly higher arginine-specific proteases 
activity than V3128 from blood and BHI plates. Figures 34 and 35 also show that W83 
has significantly higher lysine-specific protease activity than V3128 from blood and BHI 
plates. Since V3128 was previously shown to contain significantly less iron than W83, 
we can assume that the low iron levels could potentially play a significant role in 
production of proteases in P. gingivalis. A study by Carman et al. showed that P. 
gingivalis W50 strains grown in absence of hemin had significantly less trypsin-like 
protease activity then strains grown in presence of hemin (Carman et al., 1990). Hemin 
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is made from iron and protoporphyn IX which means that low hemin levels could mean 
low iron levels. These results suggest that PG0785 could be crucial to the protease 
activity of P. gingivalis.  
Our fourth aim was to determine the virulence ability of V3128 and W83 by 
performing total interaction and invasion assays. Our results showed that PG0785 can 
indirectly play a crucial role in P. gingivalis virulence. W83 and V3128 from blood plates 
were used for both total interaction and invasion assays. The number of colonies from 
all five replicates was averaged together and the results can be seen in Figures 14 and 
15. We can see based on these results, that W83 had a significantly elevated level of 
interaction with HUVEC cells than V3128. W83 also invaded HUVEC cells at a 
significantly higher level than V3128. These results suggest that the virulence of V3128 
has significantly decreased compared to W83. This decrease in virulence could be due 
to the lack of hemin attachment to the surface of V3128 and decrease in iron uptake by 
V3128. Hemin on the surface of P. gingivalis can form µ-oxo dimers which are two Iron 
(III) Meso-Tetraphenylporphines connected together by an oxygen. Generation of these   
µ-oxo dimers helps protect the bacterium in presence of reactive oxygen compounds 
(Smalley et al., 1998). We have demonstrated that V3128 cannot accumulate hemin on 
its surface and thus could be damaged in presence of reactive oxygen species. Studies 
have also demonstrated that P. gingivalis grown in hemin-limited conditions have 
decreased virulence in mouse models than those grown in hemin-excess conditions 
(McKee et al., 1986). Another group found that a P. gingivalis mutant defective in prtH 
protease had significantly less virulence than wild type (Fletcher et al., 1995). These two 
studies show that low hemin/iron concentrations and decreased protease activity can 
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lead to a decreased virulence. We have already demonstrated that V3128 has 
significantly lower iron levels and protease activity compared to W83 which could be 
one reason why V3128 virulence is decreased compared to W83.  
Flow cytometry was also done to compare the interaction and invasion ability of 
V3128 with W83. Both V3128 and W83 were labeled with FITC which allows us to 
measure fluorescence using a flow cytometer. For total interaction, bacteria were 
incubated with HUVEC cells and flouresence was measured. For invasion, bacteria 
were allowed to incubate with HUVEC cells and then Trypan blue was added to kill 
extracellular cells so that only the fluorescence of invading bacteria could be measured. 
We expected that W83 would have higher fluorescence for both interaction and 
invasion. However, what we saw with our results was the V3128 and W83 had higher 
median fluorescence then invasion but overall V3128 had higher numbers then W83 
(Figure16). Although we had shown that interaction has higher fluorescence than 
invasion, we could not figure out why V3128 had higher numbers. We believe that the 
protocol possibly needs to be changed in order for flow cytometry to give us better 
numbers.  
Proteomics was done on both W83 and V3128 to identify proteins that had been 
up-regulated and down-regulated. Both solutions and gel bands (Figure 16) were 
prepared and sent for analysis. Unfortunately we did not get usable results for our 
solutions. This could be due to protocol that we used to prepare our samples. The 
proteomics center was also down for two months thus we could not submit any more 
samples. Our gel bands, however, did yield some proteins that we were able to analyze 
using our transcriptomics results. The major proteins identified from gel bands were 
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lipoprotein RagB, RagA, 4-hydroxybutyryl-CoA dehydratase (abfD), arginine-specific 
cysteine protease, hemmagglutinin protein HagA and HagE, outer membrane 
lipoprotein Omp28 (omp28), immunoreactive 43 kDa antigen PG32, ABC transporter 
ATP-binding protein, NAD-specific glutamate dehydrogenase (GDH), peptidylarginine 
deiminase and a Dps family protein. Based on our RNA sequencing results which we 
will discuss later we were able to determine that ABC Transporter ATP-binding protein, 
HagA, HagE, arginine-specific cysteine protease, RagA and RagB were all down 
regulated and Omp28 was up-regulated. RagA and RagB are both TonB linked 
receptors on the surface of P. gingivalis and the fact that both were down-regulated in 
V3128 which has a non-functional PG0785 gene tells us that PG0785 could be a 
putative TonB protein. Arginine-protease activity was also down-regulated which 
correlates with our protease assay results which show that protease activity of V3128 
had significantly decreased compared to W83.   
The sequencing results allowed us to align the reads of the cDNA fragments with 
the P. gingivalis genome and to compare reads of W83 and V3128. Figure 25 shows 
that the four largest reads from the libraries were 16s rRNA. The kit we used was 
supposed to deplete rRNA but we have shown that it has not completely depleted the 
rRNA. We would like our libraries to have very low rRNA levels and thus we plan on 
generating another library from samples that have first been treated to have rRNA 
removed. Tables 7, 8 and 9 list the number of genes up-regulated and down-regulated 
in V3128 based on their fold change. Figures 26, 27 and 28 show the most up-regulated 
and down-regulated genes from the three different RNA sets. Our genes of interest 
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included TonB-related genes, metal uptake genes, hemin uptake genes and genes 
involved in virulence.  
We expected that our RNA sequencing results would show that PG0785 would 
be one of the most down-regulated genes in V3128 since this is the gene that we 
knocked out. Our first sequencing result from 03/06/2014 showed that PG0785 was 
down-regulated but it was not one of the most down-regulated genes as we expected. 
However, our RNA sequencing result from 4/10/2014 showed that PG0785 was the 
most down-regulated gene. Our third RNA sequencing result from 4/14/2014 showed 
that PG0785 was the 12th most down-regulated gene. This showed that we have 
significantly down-regulated the gene for our candidate TonB protein. Further analysis 
showed that many other TonB linked genes had also been down-regulated. 
 PG0668, PG0707, PG1899 and PG2008 are all identified as coding for a 
putative TonB linked outer-membrane receptors which could play a role in hemin 
binding. All four have been down-regulated in our RNA sequencing sample from 4/10. 
This is very encouraging because we would expect that down-regulation of TonB would 
lead to down-regulation of TonB-linked outer-membrane receptors. Three other 
interesting genes that have been down-regulated are hmuR, hmuY and tlr. HmuR is a 
TonB-linked outer membrane receptor that is believed to bind hemin and transport it 
across the outer membrane (Simpson et al., 2000). Our results showed that this gene 
was down-regulated in two of the three sequencing results. Down-regulation of this 
gene could explain why V3128 does not accumulate hemin on its surface compared to 
W83. HmuY is also a hemin binding protein and Tlr is TonB-linked hemin binding 
receptor on the surface of P. gingivalis (Nelson et al., 2003). The genes coding for these 
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proteins have been down-regulated in all three of our RNA sequencing results which 
provides further evidence for the lack of hemin accumulation on surface of P. gingivalis 
and could also affect hemin transport across the cell. 
 PG1875 is believed to be a hemolysin involved in breakdown of hemin 
containing proteins which allows for release of hemin and uptake by P. gingivalis. This 
gene has been down-regulated in all three RNA sequencing results. Down-regulation of 
this gene hinders the ability of V3128 to breakdown hemin containing proteins leading to 
a decrease in available hemin and iron. This could also attribute to the lack of hemin 
accumulation on surface of V3128 and the significantly lower iron levels seen in our 
metal content assay result. Since P. gingivalis obtains the majority of its iron in the form 
of hemin, then down-regulation of these genes could also attribute to the decrease of 
iron in V3128. Down-regulation of PG0668, PG0707, PG1899, PG2008, hmuR, hmuY, 
tlr and PG1875 in V3128 tells us that PG0785 could be very important in binding and 
uptake of hemin in P. gingivalis, a process that TonB is believed to play an important 
role in. 
We were also interested in genes coding for proteins involved in virulence of P. 
gingivalis to determine if PG0785 plays a role in virulence of the bacterium. 
Hemagglutinins are important in the adherence of the bacteria with eukaryotic cells and 
play a major role in virulence of P. gingivalis. Our RNA sequencing results showed that 
hemagglutinin genes hagA, hagB and hagC were mostly down-regulated. This could 
attribute to the significant decrease seen in the virulence of V3128. The capA gene is 
involved in encapsulation of P. gingivalis. Capsules help protect the bacteria against the 
immune system and also play an important role in virulence of P. gingivalis. The capA 
 84 
 
gene was significantly down-regulated in one of our RNA sequences. Down-regulation 
of this gene could also attribute to the significant decrease seen in virulence of V3128. 
Proteases are involved in breaking down hemin-containing proteins and also play a 
major role in virulence of P. gingivalis. Arginine-specific cysteine protease (PrtRII) was 
slightly up-regulated in two of the RNA sequences and significantly down-regulated in 
one of the sequences. Down-regulation of this gene could provide evidence for both 
decrease of virulence and protease activity seen in V3128. Hemin on surface of P. 
gingivalis also plays a role in protecting the bacteria from reactive oxygen species. 
Down-regulation of gene involved in hemin-binding could also provide evidence for the 
decrease in virulence of V3128. Overall, knocking out PG0785 resulted in mostly down-
regulation of genes involved in virulence which indicates that PG0785 could play a 
significant role in virulence of P. gingivalis. 
 We have already shown that iron levels had been significantly reduced in V3128. 
As a result we expected that genes involved in iron uptake would be down-regulated in 
V3128. PG0646, PG0647, PG0648, PG0671 and PG0672 are all genes coding for 
proteins that are part of the iron compound ABC transporter which is involved in uptake 
of iron in P. gingivalis (Nelson et al., 2003). Two of our sequencing results showed that 
all five genes had been down-regulated in V3128. Down regulation of these genes could 
explain why there is significantly lower level of iron in V3128 compared to W83. RagA is 
a TonB linked outer-membrane receptor involved in iron uptake (Nelson et al., 2003). 
The ragA gene was also down-regulated in two of our sequencing results. Down-
regulation of this gene could also provide evidence for the significant decrease of iron in 
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V3128. Overall down-regulation of these genes due to mutation of PG0785 shows that 
PG0785 could play an important role in iron uptake. 
In conclusion, we were able to demonstrate that PG0785 is important in binding 
of hemin to surface of P. gingivalis. We were also able to show that PG0785 plays an 
important role in uptake of iron, protease activity and virulence of P. gingivalis. V3128 
contains significantly less iron than W83. This lack of iron due to disruption of PG0785 
could be the reason why protease activity and virulence of P. gingivalis were 
significantly decreased. Translational and transcriptional analysis of V3128 showed us 
that numerous TonB-related genes, metal uptake genes, hemin uptake genes and 
genes involved in virulence had been down-regulated in V3128. Down-regulation of 
these genes suggests that PG0785 is a very important protein in the biology of P. 
gingivalis. It is important to note that the TonB protein in other bacteria has also been 
shown to play important roles in the biology of those bacteria. Although we have shown 
that PG0785 plays an important role in P. gingivalis, we cannot make the assumption 
that PG0785 codes for the TonB protein. TonB is involved in energy transduction in 
other bacterial species thus further investigation of mechanisms of energy transduction 
in P. gingivalis needs to be done. If PG0785 is shown to play a crucial role in energy 
transduction in P. gingivalis then that provides more definitive evidence that PG0785 is 
the TonB protein of P. gingivalis.  
 
  
 86 
 
Literature Cited 
Aduse-Opoku, J., Slaney, J. M., Rangarajan, M., Muir, J., Young, K. A. & Curtis, M. A. 
(1997). The Tla protein of Porphyromonas gingivalis W50: a homolog of the RI protease 
precursor (PrpRI) is an outer membrane receptor required for growth on low levels of 
hemin. J Bacteriol 179, 4778–4788. 
 
Al-Qutub MN, Braham PH, Karimi-Naser LM, Liu X, Genco CA & Darveau RP. 2006. 
Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis 
lipopolysaccharide. Infect Immun 74: 4474–4485 
Albandar JM, Rams TE. Periodontol 2000 Global epidemiology of periodontal diseases 
29. Copenhagen, Denmark: Munksgaard Blackwells, 2002.  
Albandar, J. M., J. A. Brunelle, and A. Kingman. 1999. Destructive periodontal disease 
in adults 30 years of age and older in the United States, 1988-1994. J. Periodontol. 
70:13-29 
Amar S, Gokce N, Morgan S, Loukideli M, Van Dyke TE, Vita JA. Periodontal disease is 
associated with brachial artery endothelial dysfunction and systemic inflammation. 
Arterioscler Thromb Vasc Biol. 2003;23:1245–9. 
 
Amar S, Han X. The impact of periodontal infection on systemic diseases. Med Sci 
Monit. 2003;9:RA291–9. 
 
Bahekar AA, Singh S, Saha S, Molnar J, Arora R. The prevalence and incidence of 
coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am 
Heart J. 2007: 154: 830–837. 
Baggiolini M, Dewald B, Waltz A (1992). Inflammation: basic principles and clinical 
correlates. In: Interleukin-8 and related chemotacitic chemokines. Gallin JI, Goldstein 
IM, Synderman R, editors. New York: Raven Press, pp. 247-263. 
Baker P, Dixon M,Evans R,Dufour L,Johnson E, Roopenian D(1999). CD4(+)T cells and 
the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar 
bone loss in mice. Infect Immun 67:2804-2809. 
Beck JD, Offenbacher S, Williams R, Gibbs P, Garcia R. 1998. Periodontitis: a risk 
factor for coronary heart disease? Ann. Periodontol. 3:127–141. 
Belibasakis GN, Bostanci N & Reddi D (2010) Regulation of protease-activated 
receptor-2 expression in gingival fibroblasts and Jurkat T cells by Porphyromonas 
gingivalis. Cell Biol Int 34: 287–292. 
Boukhalfa H, Crumbliss AL. Chemical aspects of siderophore mediated iron transport. 
Biometals 2002: 15: 325–339. 
 87 
 
Bradbeer C. 1993. The proton motive force drives the outer membrane transport of 
cobalamin in Escherichia coli. J Bacteriol 175(10):3146-3150.  
Bridges K. R., Seligman P. A. (1995). “Disorders of iron metabolism,” in Blood: 
Principles and Practice of Hematology, eds Handin R. I., Lux S. E., Stossel T. P., 
editors. (Philadelphia, PA: JB Lippincott Company; ), 1433–1472. 
Brochu, V., Grenier, D., Nakayama, K., Mayrand, D. (2001) Acquisition of iron from 
human transferrin by Porphyromonas gingivalis: a role for Arg- and Lys-gingipain 
activities. Oral. Microbiol. Immunol. 16, 79–87. 
 
Brown L J, Oliver R C, Loe H. Periodontal diseases in the U.S. in 1981: prevalence, 
severity, extent, and role in tooth mortality. J Periodontol. 1989;60:363–370. 
 
Brockwell DJ, Paci E, Zinober RC, Beddard GS, Olmsted PD, Smith DA, et al.. 2003. 
Pulling geometry defines the mechanical resistance of a β-sheet protein. Nat. Struct. 
Biol. 10(9): 731-737. 
Brunner J, Scheres N, El Idrissi NB, et al. The capsule of Porphyromonas gingivalis 
reduces the immune response of human gingival fibroblasts. BMC Microbiol. 2010;10:5.  
Cascales E, Lloubès R, Sturgis JN. 2001. The TolQ-TolR proteins energize TolA and 
share homologies with the flagellar motor proteins MotA-MotB. Mol. Microbiol. 42(3): 
795-807. 
Carman, R.J., M.D. Ramakrishnan, and F.H.Harper. 1990. Hemin levels in culture 
medium of Porphyromonas (Bacteroides) gingivalis regulate both hemin binding and 
trypsin-like protease production. Infect. Immun.58:4016–4109 
 
Carter DM, Miousse IR, Gagnon JN, Martinez E, Clements A, Lee J, et al.. 2006. 
Interactions between TonB from Escherichia coli and the periplasmic protein FhuD. J. 
Biol. Chem. 281(46): 35413-35424. 
Chu, L., Bramanti, T.E., Ebersole, J.L., Holt, S.C. (1991) Hemolytic activity in the 
periodontopathogen Porphyromonas gingivalis: Kinetics of enzyme release and 
localization. Infect. Immun. 59, 932–1940. 
Cornelissen CN, Sparling PF. 1994. Iron piracy: acquisition of transferrin-bound iron by 
bacterial pathogens. Mol Microbiol 14:843-50. 
Curtis MA, duse-Opoku J, Rangarajan M. Cysteine proteases of Porphyromonas 
gingivalis. Crit Rev Oral Biol Med. 2001;12:192–216. 
Dashper, S. G., Hendtlass, A., Slakeski, N., Jackson, C., Cross, K. J., Brownfield, L., 
Hamilton, R., Barr, I. & Reynolds, E. C. (2000). Characterization of a novel outer 
 88 
 
membrane hemin-binding protein of Porphyromonas gingivalis. J Bacteriol 182, 6456–
6462. 
 
Darveau RP, Tanner A & Page RC. The microbial challenge in periodontitis. Periodontol 
2000. 1997: 14: 12–32. 
Darveau, R. P., Periodontitis: a polymicrobial disruption of host homeostasis. Nat. Rev. 
Microbiol. 2010. 8: 481–490. 
Darveau, R. P., Belton, C. M., Reife, R. A. and Lamont, R. J., Local chemokine 
paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect. Immun. 
1998. 66: 1660–1665. 
DePamphilis, M.L., and Adler, J. 1971. Fine structure and isolation of the hook-basal 
body complex of flagella from Escherichia coli and Bacillus subtilis. J. Bacteriol. 105(1): 
384-395. 
Dorn BR, Dunn WA, Jr, Progulske-Fox A. 2001. Porphyromonas gingivalis traffics to 
autophagosomes in human coronary artery endothelial cells. Infect. Immun. 69:5698–
5708. 
Elter JR, Champagne CME, Offenbacher S, Beck JD. Relationship of periodontal 
disease and tooth loss to prevalence of coronary heart disease. J Periodontol. 
2004;75:782–90 
 
Fletcher, H. M., H. A. Schenkein, R. M. Morgan, K. A. Bailey, C. R. Berry, and F. L. 
Macrina. 1995. Virulence of a Porphyromonas gingivalis W83 mutant defective in the 
prtH gene. Infect. Immun. 63:1521-1528. 
Fujimura S, Hirai K, Shibata Y, Nakayama K, Nakamura T. Comparative properties of 
envelope-associated arginine-gingipains and lysine-gingipain of Porphyromonas 
gingivalis. FEMS Microbiol Lett. 1998;163:173–179. 
Gumbart J, Wiener MC, Tajkhorshid E. 2007. Mechanics of force propagation in TonB-
dependent outer membrane transport. Biophys. J. 93(2): 496-504. 
Harley, J. B., J. G. Flaks, H. Goldfine, M. E. Bayer, and H. Rasmussen. 1981. 
Hyperbaric oxygen toxicity and ribosome destruction in Escherichia coli K12. Can. J. 
Microbiol. 27:44-51. 
Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev 
Microbiol. 2012;14(10):717–725. doi: 10.1038/nrmicro2873. 
Horning GM, Hatch CL & Cohen ME. Risk indicators for periodontitis in a military 
treatment population. J Periodontol. 1992: 63: 297–302. 
 89 
 
Holt, S. C. & Ebersole, J. L. Porphyromonas gingivalis, Treponema denticola, and 
Tannerella forsythia: the “red complex”, a prototype polybacterial pathogenic consortium 
in periodontitis. Periodontol. 2000 38, 72–122 (2005). 
Hrkal Z, Vodrazka Z, Kalousek I. Transfer of heme from ferrihemoglobin and 
ferrihemoglobin isolated chains to hemopexin. Eur J Biochem. 1974;43:73–78. 
 
Hujoel PP, Drangsholt MT, Spiekerman C, Derouen TA. Periodontitis-systemic disease 
associations in the presence of smoking: causal or coincidental? J Periodontol. 2000 
2002;30:51–60. 
 
Hwang PK, Greer J. Interaction between hemoglobin subunits in the hemoglobin. 
haptoglobin complex. J Biol Chem. 1980;255:3038–3041. 
 
Imlay, J. A. 2002. How oxygen damages microbes: oxygen tolerance and obligate 
anaerobiosis. Adv. Microb. Physiol. 46:111-153. 
 
Imamura T. The role of gingipains in the pathogenesis of periodontal disease. J 
Periodontol. 2003;74:111–118. 
 
Imamura T, Banbula A, Pereira PJ, Travis J & Potempa J (2001) Activation of human 
prothrombin by arginine-specific cysteine proteinases (Gingipains R) from 
Porphyromonas gingivalis. J Biol Chem 276: 18984–18991. 
 
Jordan LD, Zhou Y, Smallwood CR, et al. Energy-dependent motion of TonB in the 
Gram-negative bacterial inner membrane. Proc Natl Acad Sci USA. 
2013;110(28):11553-8. 
Kamaguchi, A., Ohyama, T., Sakai, E., Nakamura, R., Watanabe, T., Baba, H., 
Nakayama, K. (2003) Adhesions encoded by the gingipain genes of Porphyromonas 
gingivalis are responsible for co-aggregation with Prevotella intermedia. Microbiology 
149, 1257–1264. 
Kampfenkel, K., and Braun, V. 1993. Topology of the ExbB protein in the cytoplasmic 
membrane of Escherichia coli. J. Biol. Chem. 268(8): 6050-6057.  
 
Kampfenkel, K., and Braun, V. 1992. Membrane topology of the Escherichia coli ExbD 
protein. J. Bacteriol. 174(16): 5485-5487. 
 
Kelley LA and Sternberg MJE. 2009. Protein structure prediction on the web: a case 
study using Phyre server. Nature Protocols 4:363-371. 
Kitamura Y, Matono S, Aida Y, Hirofuji T & Maeda K (2002) Gingipains in the culture 
supernatant of Porphyromonas gingivalis cleave CD4 and CD8 on human T cells. J 
Periodontal Res 37: 464–468. 
 90 
 
Kozarov EV, Dorn BR, Shelburne CE, Dunn WA, Jr., Progulske-Fox A. Human 
atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans 
and Porphyromonas gingivalis. Arterioscler. Thromb. Vasc. Biol. 2005;25:e17. 
 
Köhler SD, Weber A, Howard SP, Welte W, Drescher M. 2010. The proline-rich domain 
of TonB possesses an extended polyproline II-like conformation of sufficient length to 
span the periplasm of Gram-negative bacteria. Protein Sci. 19(4): 625-630. 
 
Kumar PS, Griffen AL, Moeschberger ML, Leys EJ. Identification of candidate 
periodontal pathogens and beneficial species by quantitative 16S clonal analysis. J Clin 
Microbiol. 2005;43:3944–55. 
 
Larsen, R. A., M. G. Thomas, and K. Postle. 1999. Protonmotive force, ExbB and 
ligand-bound FepA drive conformational changes in TonB. Mol. Microbiol. 31:1809-
1824. 
 
Larsen RA, Foster-Hartnett D, McIntosh MA, Postle K. 1997. Regions of Escherichia 
coli TonB and FepA proteins essential for in vivo physical interactions. J. Bacteriol. 
179(10): 3213-3221. 
 
Lamont RJ, Jenkinson HF. Life below the gum line: pathogenic mechanisms of 
Porphyromonas gingivalis. Microbiol Mol Biol Rev. 1998;62:1244–1263. 
 
Lewis JP, Yanamandra SS, Anaya-Bergman C (2012) HcpR of Porphyromonas 
gingivalis is required for growth under nitrosative stress and survival within host cells. 
Infect Immun 80: 3319–3331. 
 
Lewis J P, Dawson J A, Hannis J C, Muddiman D, Macrina F L. Hemoglobinase activity 
of the lysine gingipain protease (Kgp) of Porphyromonas gingivalis W83. J Bacteriol. 
1999;181:4905–4913. 
 
Letain T. E., Postle K.(1997) TonB protein appears to transduce energy by shuttling 
between the cytoplasmic membrane and the outer membrane in Gram-negative 
bacteria. Mol. Microbiol. 24:271–283. 
Lindemann R. A., Economou J. S., Rothermel H. (1988) Production of interleukin-1 and 
tumor necrosis factor by human peripheral monocytes activated by periodontal bacteria 
and extracted lipopolysaccharides. J. Dent. Res. 67:1131–1135. 
Liu X, Olczak T, Guo HC, Dixon DW, Genco CA. Identification of amino acid residues 
involved in heme binding and hemoprotein utilization in the Porphyromonas gingivalis 
heme receptor HmuR. Infect Immun 2006: 74: 1222–1232. 
Loesche WJ, Grossman NS. Periodontal disease as a specific, albeit chronic, infection: 
diagnosis and treatment. Clin Microbiol Rev. 2001;14:727–52. 
 
 91 
 
Lopez NJ, Smith PC, Gutierrez J. Higher risk of preterm birth and low birth weight in 
women with periodontal disease. J Dent Res. 2002; 81(1): 58–63. 
 
Lourbakos A, Chinni C, Thompson P, Potempa J, Travis J, Mackie EJ & Pike RN (1998) 
Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by 
gingipain-R from Porphyromonas gingivalis. FEBS Lett 435: 45–48. 
 
Lourbakos A, Potempa J, Travis J et al. (2001) Arginine-specific protease from 
Porphyromonas gingivalis activates protease-activated receptors on human oral 
epithelial cells and induces interleukin-6 secretion. Infect Immun 69: 5121–5130. 
Lynch, M. C., and H. K. Kuramitsu. 1999. Role of superoxide dismutase activity in the 
physiology of Porphyromonas gingivalis. Infect. Immun. 67:3367-3375. 
Macy, J., Probst, I., Gottschalk, G. 1975. Evidence for cytochrome involvement in 
fumarate reduction and adenosine 5’-triphosphate synthesis by Bacteriodes fragilis 
grown in the presence of hemin. J Bacteriol 123, 436-442.  
 
Mahanonda R, Seymour G, Powell L, Good M & Halliday J. Effect of initial treatment of 
chronic inflammatory periodontal disease on the frequency of peripheral blood T-
lymphocytes specific to periodontopathic bacteria. Oral Microbiol Immunol 1991: 6: 
221–227. 
 
Matto J, Saarela M, Alaluusua S, Oja V, Jousimies-Somer H, Asikainen S. Detection of 
Porphyromonas gingivalis from saliva by PCR by using a simple sample-processing 
method. J Clin Microbiol. 1998;36:157–160. 
 
McKee A. S., McDermid A. S., Baskerville A., Dowsett B., Ellwood D. C., Marsh P. D. 
(1986) Effect of hemin on the physiology and virulence of Bacteroides gingivalis W50. 
Infect. Immun. 52:349–455. 
 
Mikolajczyk-Pawlinska J, Kordula T, Pavloff N, et al. Genetic variations of 
Porphyromonas gingivalis genes encoding gingipains, cysteine proteinases with 
arginine or lysine specificity. Biol Chem 1998;379:205-211.  
 
Moeck, G. S., and L. Letellier. 2001. Characterization of in vitro interactions between a 
truncated TonB protein from Escherichia coli and the outer membrane receptors FhuA 
and FepA. J. Bacteriol. 183:2755-2764. 
 
Nakayama, K., Kadowaki, T., Okamoto, K. and Yamamoto, K. (1995) Construction and 
characterization of arginine-specific cysteine proteinase (Arg-gingipain)-deficient 
mutants of Porphyromonas gingivalis. Evidence for significant contribution of Arg-
gingipain to virulence. J. Biol. Chem. 270, 23619–23626. 
 
Nakayama K, Ratnayake DB, Tsukuba T, Kadowaki T, Yamamoto K, Fujimura S. 
Haemoglobin receptor protein is intragenically encoded by the cysteine proteinase-
 92 
 
encoding genes and the haemagglutinin-encoding gene of Porphyromonas gingivalis. 
Mol Microbiol 1998: 27: 51–61. 
 
Nelson, K.E., Fleischmann, R.D., DeBoy, R.T., Paulsen, I.T., Fouts, D.E., Eisen, J.A., 
Daugherty, S.C., Dodson, R.J., Durkin, A.S., Gwinn, M., Haft, D.H., Kolonay, J.F., 
Nelson, W.C., Mason, T., Tallon, L., Gray, J., Granger, D., Tettelin, H., Dong, H., Galvin, 
J.L., Duncan, M.J., Dewhirst, F.E., Fraser, C.M. (2003) Complete genome sequence of 
the oral pathogenic bacterium Porphyromonas gingivalis strain W83. J. Bacteriol. 185, 
5591–5601. 
 
Nelson, K. E., Fleischmann, R. D., DeBoy, R. T. & 20 other authors (2003). Complete 
genome sequence of the oral pathogenic bacterium Porphyromonas gingivalis strain 
W83. J Bacteriol 185, 5591–5601. 
 
Nikaido H (2003) Molecular basis of bacterial outer membrane permeability revisited. 
Microbiol Mol Biol Rev 67(4):593-656. 
Nonaka, E., Kiyama-Kishikawa, M., Hayakawa, M. (2001) Identification of 40-kDa outer 
membrane protein as an aggregation factor of Porphyromonas gingivalis to 
Streptococcus gordonii. J. Oral Sci. 43, 239–243. 
Okuda K, Kimizuka R, Abe S, Kato T, Ishihara K. Involvement of periodontopathic 
anaerobes in aspiration pneumonia. J. Periodontol. 2005;76:2154. 
Olczak T, Siudeja K, Olczak M. Purification and initial characterization of a novel 
Porphyromonas gingivalis HmuY protein expressed in Escherichia coli and insect cells. 
Protein Expr Purif 2006: 49: 299–306. 
Oliver RC & Tervonen T. Periodontitis and tooth loss: comparing diabetics with the 
general population. J Am Dent Assoc. 1993: 124: 71–76. 
Otto BR, Verweij-van Vught AM, MacLaren DM. Transferrins and heme-compounds as 
iron sources for pathogenic bacteria. Crit Rev Microbiol. 1992;18:217–233. 
Park, M. K., R. A. Myers, and L. Marzella. 1992. Oxygen tensions and infections: 
modulation of microbial growth, activity of antimicrobial agents, and immunologic 
responses. Clin. Infect. Dis. 14:720-740. 
 
 
Pavloff N, Potempa J, Pike RN, Prochazka V, Kiefer MC, Travis J, Barr PJ. Molecular 
cloning and structural characterization of the Arg-gingipain proteinase of 
Porphyromonas gingivalis. Biosynthesis as a proteinase-adhesin polyprotein. J Biol 
Chem. 1995 Jan 20;270(3):1007–1010. 
 
 93 
 
Pawelek PD, Croteau N, Ng-Thow-Hing C, Khursigara CM, Moiseeva N, et al. 2006. 
Structure of TonB in complex with FhuA, E. Coli outer membrane receptor. Science 
312:1399-402. 
 
Pike RN, Potempa J, McGraw W, Coetzer TH, Travis J. Characterization of the binding 
activities of proteinase-adhesin complexes from Porphyromonas gingivalis. J Bacteriol. 
1996;178:2876–2882. 
 
Popadiak K, Potempa J, Riesbeck K, Blom AM. Biphasic effect of gingipains from 
Porphyromonas gingivalis on the human complement system. J. Immunol. 
2007;178:7242. 
 
Potempa J, Pavloff N, Travis J. Porphyromonas gingivalis: A protease/gene accounting 
audit. Trend Microbiol 1995;3:430-434.  
 
Potempa J, Sroka A, Imamura T, Travis J. Gingipains, the major cysteine proteinases 
and virulence factors of Porphyromonas gingivalis: structure, function and assembly of 
multidomain protein complexes. Curr Protein Pept Sci. 2003 Dec;4(6):397–407. 
 
Progulske-Fox A, Tumwasorn S, Lepine G, Whitlock J, Savett D, Ferretti JJ, Banas JA. 
The cloning, expression and sequence analysis of a second Porphyromonas gingivalis 
gene that codes for a protein involved in hemagglutination. Oral Microbiol Immunol. 
1995;10:311–318. 
Sandros J, Papapanou PN, Nannmark U, Dahlén G. Porphyromonas gingivalis invades 
human pocket epithelium in vitro. J Periodontal Res. 1994 Jan;29(1):62–69. 
Sauter A, Howard SP, Braun V. 2003. In vivo evidence for TonB dimerization. J. 
Bacteriol. 185:5747–5754. 
 
Schenkein HA, Fletcher HM, Bodnar M & Macrina FL (1995) Increased opsonization of 
a prtH-defective mutant of Porphyromonas gingivalis W83 is caused by reduced 
degradation of complement-derived opsonins. J Immunol 154: 5331–5337. 
 
Shultis DD, Purdy MD, Banchs CN, Wiener MC. 2006. Outer membrane active 
transport: structure of the BtuB:TonB complex. Science 312:1396-99.  
Schifferle RE, Shostad SA, Bayers-Thering MT, Dyer DW, Neiders ME. Effect of 
protoporphyrin IX limitation on Porphyromonas gingivalis. J Endod. 1996;22:352–355. 
Shah, H. N., and M. D. Collins. 1988. Proposal for the reclassification of Bacteroides 
asaccharolyticus, Bacteroides gingivalis, and Bacteroides endodontalis in a new genus, 
Porphyromonas. Int. J. Syst. Bacteriol. 38:128-131. 
Shah, H. N., R. Bonnet, B. Mateen, and R. A. D. Williams. 1979. The prophyrin 
pigmentation of subspecies of Bacteroides melaningenicus. Biochem. J. 180: 45-50.  
 94 
 
Shizukuishi S, Tazaki K, Inoshita E, Kataoka K, Hanioka T, Amano A. Effect of 
concentration of compounds containing iron on the growth of Porphyromonas gingivalis. 
FEMS Microbiol Lett. 1995;131:313–317. 
Simpson W, Olczak T, Genco CA. Characterization and expression of HmuR, a TonB-
dependent hemoglobin receptor of Porphyromonas gingivalis. J Bacteriol 2000: 182: 
5737–5748. 
 
Slakeski, N., Dashper, S. G., Cook, P., Poon, C., Moore, C. & Reynolds, E. C. (2000). A 
Porphyromonas gingivalis genetic locus encoding a heme transport system. Oral 
Microbiol Immunol 15, 388–392. 
Smalley, J. W., J. Silver, P. J. Marsh, and A. J. Birss. 1998. The periodontopathogen 
Porphyromonas gingivalis binds iron protoporphyrin IX in the mu-oxo dimeric form: an 
oxidative buffer and possible pathogenic mechanism. Biochem. J. 331681-685. 
Smalley JW, Birss AJ, Withnall R, Silver J. Interactions of Porphyromonas gingivalis 
with oxyhaemoglobin and deoxyhaemoglobin. Biochem J 2002: 362: 239–245.  
Socransky, S. S., and A. D. Haffajee. 1994. Evidence of bacterial etiology: a historical 
perspective. Periodontol. 2000 5:7-25. 
Soskoln WA, Klinger A. The relationship between periodontal diseases and diabetes: an 
overview.  Ann Periodontol 2001;  6:91–98. 
 
Sroka, A.E., Sztukowska, M., Potempa, J., Travis, J., Genco, C.A. (2001) Degradation 
of host-heme proteins by the lysine- and arginine-specific cysteine proteinases 
(gingipains) of Porphyromonas gingivalis. J. Bacteriol. 183, 5609–5616.  
 
Stoltenberg Jl, Osborn JB, Pihlstrom BL, Herzberg MC, Aeppli DM, Wolff LF & Fischer 
GE. Association between cigarette smoking, bacterial pathogens, and periodontal 
status. J Periodontol. 1993: 64: 1225–1230. 
Sztukowska, M., M. Bugno, J. Potempa, J. Travis, and D. M. Kurtz. 2002. Role of 
rubrerythrin in the oxidative stress response of Porphyromonas gingivalis. Mol. 
Microbiol. 44:479-488. 
Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: 
an epidemiologic perspective. Ann Periodontol 2001; 6: 99–112. 
 
Teles R, Teles F, Frias-Lopez J, Paster B, Haffajee A. Lessons learned and unlearned 
in periodontal microbiology. Periodontol 2000. 2013;62:95–162. 
Wolfe MT, Heo J, Garavelli JS, Ludden PW. 2002. Hydroxylamine reductase activity of 
the hybrid cluster protein from Escherichia coli. J. Bacteriol. 184:5898–5902. 
 95 
 
Wingrove JA, DiScipio RG, Chen Z, Potempa J, Travis J & Hugli TE (1992) Activation of 
complement components C3 and C5 by a cysteine proteinase (gingipain-1) from 
Porphyromonas (Bacteroides) gingivalis. J Biol Chem 267: 18902–18907. 
Yang HW, Huang YF & Chou MY (2004) Occurrence of Porphyromonas gingivalis and 
Tannerella forsythensis in periodontally diseased and healthy subjects. J Periodontol 
75: 1077–1083. 
 
